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CATIONIC AMPHIPHILIC SYNTHETIC MACROMOLECULES WITH 
SUPERIOR ANTIBACTERIAL ACTIVITY 
by 
Ashish Punia 
Adviser: Professor Nan-Loh Yang  
The increasing prevalence of antibiotic resistant bacteria (superbugs) has created a pressing need 
for new systems of antimicrobial agents. In this dissertation, I report on my extensive research on 
the design, synthesis, and development of synthetic amphiphilic macromolecules with 
antimicrobial activity and very low hemolytic impact. Synthetic amphiphilic polymers attack 
bacteria directly to rupture the cell membrane through electrostatic and hydrophobic interactions. 
However, the toxicity of such synthetic amphiphilic polymers against mammalian cells have 
impeded their therapeutic applications. We investigated the systematic structure/activities 
relationships for antibacterial and hemolytic activities of amphiphilic polyacrylates and poly(vinyl 
esters). Acrylate homopolymers with various lengths of alkyl pendant groups displayed high 
antibacterial activity against Staphylococcus aureus (S. aureus) and very low hemolytic activity 
toward red blood cells (RBCs). In comparison with polyacrylate homopolymers, random 
copolymers were highly antibacterial but extremely hemolytic. To further improve antibacterial 
activity of polyacrylates, while maintaining low hemolytic activity, a series of copolymers with 2-
carbon and 6-carbon spacer arm (distance between polymer backbone and cationic center) counits 
were investigated. Our strategy of controlling charge distribution and mole ratios of 2-carbon (M2) 
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and 6-carbon counits (M6) resulted in a polymer with >200 fold selectivity toward Escherichia 
coli (E. coli) over RBCs. Copolymerization of just 10 mole% of shorter spacer arm M2 counits 
with hydrophobic M6 counits led to a drastic reduction in hemolytic activity by a factor of 850 
compared with highly hemolytic M6 homopolymer, without severe deterioration of antibacterial 
activity. Scanning electron microscopy analysis of bacterial cells established the membrane rupture 
action of these polymers.  
In a second acrylate system, hydrophilic and biocompatible poly(ethylene glycol) (PEG) 
monomers were copolymerized with M6 monomer to achieve selective (bacteria over RBCs) 
antibacterial activity in polymers. Incorporation of 30 mole% of PEG monomer led to a polymer 
with >100 times selectivity toward E. coli over RBCs. The Hydrogen-bonding ability of the PEG 
segments plays significant roles.   
For a third system of poly(vinyl ester), we explored the role of hydrophobic side groups, molecular 
weight, and  amphiphilicity on its  activities. 
This dissertation investigation has led to one of the most promising synthetic polymer systems 
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with TFA(600 MHz, CDCl3). 
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Minimum Inhibitory Concentrations of 6k g/mol series polymers 
toward E. coli 
 
Minimum Inhibitory Concentrations of 1.6k g/mol series polymers 
toward E. coli 
 
Minimum Inhibitory Concentrations of 6k g/mol series polymers 
toward S. aureus  
 
Minimum Inhibitory Concentrations of 1.6k g/mol series polymers 
toward E. coli  
 
Hemolytic activity (HC50) of 6k g/mol series polymers against RBCs 
 
Hemolytic activity (HC50) of 1.6k g/mol series polymers against 
RBCs 
 
Biological activity (MIC and HC50) of 6k g/mol series polymers. 
 
Biological activity (MIC and HC50) of 1.6k g/mol series polymers. 
 
Biological activity (MIC and HC50) of random copolymers with 
















































Graph showing that the actual mole % of M6 counits in the 
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FE-SEM image of E. coli cells treated with PM6-90-PEG950 show 
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Figure 5.10 Antibacterial and hemolytic activities of 11k g/mol series quaternized 
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Time-dependent killing efficiency of PM6-90% toward E. coli. 
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Time-dependent killing efficiency of polymers toward S. aureus. 
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Natural antimicrobial peptide mimesis and overview of structure activity 
relationships in synthetic amphiphilic polymers 
1.1 Introduction 
The discovery of penicillin by Alexander Fleming in 19281 and its subsequent mass production 
and distribution in 1940s has been hailed as one of the greatest medical achievements in modern 
history. The antibiotic “penicillin” saved thousands of lives worldwide, and the threat to human 
health from microbial infections seemed surmountable. In his Nobel Prize lecture, Fleming 
hypothesized that penicillin resistant microbes would result, if the “ignorant man” under-doses 
himself with penicillin.2 Unfortunately, Fleming’s hypothesis has become the grim reality of today. 
More than 20,000 people die in the United States alone each year from infections involving 
antibiotic drug resistant bacteria.3 Nosocomial infections add billions of dollars in health care costs 
every year.3 There has been an undeterred rise in infections involving multi-antibiotic drug 
resistant bacteria, which have come to be known as “Super bugs.”4 Widespread infections 
involving vancomycin-resistant Enterococci, methicillin-resistant Staphylococcus aureus, and 
fluoroquinolone-resistant Pseudomonas aeruginosa, among others, have threatened to undo a 
century of medical advances.5 The problem of superbugs is further compounded by the ever 
reducing efforts in the development of new antibiotics.6 The development of new antibiotic drugs 
involve huge costs, and then rapid development of bacterial resistance renders them ineffective 
within a few years.4a Hence, there is a pressing need to develop new antibacterial agents toward 
which the development of bacterial resistance would be highly hindered.7 Minimal toxicity of new 
antibiotic agents toward host mammalian cells and their facile synthesis to enable cost-effective 
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production is essential for their wide scale applications. The goal of this dissertation research is to 
synthesize polymers with high antibacterial activity and concomitant low toxicity toward 
mammalian cells. We explored structure-activity relationships in amphiphilic polyacrylates and 
poly(vinyl esters), which mimic the inherent design principles, rather than the exact structural 
features, of natural host-defense antimicrobial peptides.  
1.2 Host-defense antimicrobial peptides and their mode of antibacterial action 
Natural host-defense antimicrobial peptides (AMPs) have played an essential role in the successful 
evolution of multicellular organisms by defending them from microbial infections for millions of 
years.8 AMPs form an integral part of multicellular organism’s innate immune response to 
microbial attack. A large variety of AMPs, such as magainin in African clawed frog,9 cecropin in 
silk moth,10 and defensins11 in humans have been identified and isolated. Despite the great 
diversity in peptide sequence and secondary structures, all AMPs share the common design 
features of small size (10 to 50 amino acids) and amphiphilicity resulting from cationic and 
hydrophobic side groups.8, 12 In contrast to target specific and enzyme or DNA replication 
inhibiting action of conventional antibiotics, the amphiphilic structure of AMPs enables them to 
bind to the negatively charged outer surface of bacterial cell membrane through non-specific 
electrostatic interactions and the hydrophobic groups of AMPs facilitate their insertion into 
lipophilic core of lipid bilayer of bacteria.13-16 This non-specific attack of AMPs on the bacterial 
membrane leads to bacterial membrane permeabilization, hole formation, and leakage of 
cytoplasm etc., ultimately leading to the bacterial cell death.8,17 The development of bacterial 
resistance toward AMPs has not been documented, and is considered to be highly impeded or 
improbable, as drastic mutations in bacterial cell membrane morphology and compositions would 
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be required to gain resistant against the physical nature of membrane rupture and disruption by 
AMPs.8 
 
Figure 1.1 Selective activity of AMPs against bacteria due to significant differences in cell 
membrane composition of bacteria and mammalian cells. Figure adopted from Zasloff M., Nature 
2002, 415, 389. 
 
The fundamental differences in the cell membrane composition and morphology of bacterial and 
eukaryotic cells can explain the selective activity of AMPs toward bacterial cells and low toxicity 
against eukaryotic cells (Figure 1.1).8 The lipid bilayer of a bacterial cell is mainly comprised of 
the negatively charged phospholipids like: phosphatidylserine (PS) and phosphatidyl glycerol 
(PG).18-20 On the other hand, the outer leaflet of eukaryotic cell membrane consists of zwitterionic 
phospholipids like: phosphatidyl choline (PC) and sphingomyelin (SM), along with cholesterol.18-
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20 Moreover, bacterial cells (with some exceptions) have an additional outer coverage of a cell wall 
consisting of cross linked negatively charged peptidoglycans (murein layer).21 Thus, AMPs have 
strong electrostatic attraction to bind to the negatively charged bacterial cell surface, whereas only 
weaker hydrophobic interactions could take place between mammalian cells and AMPs, resulting 
in the selective activity of AMPs against bacteria.  
Several mechanism have been proposed for the membrane rupture activity of AMPs.22-25 In the 
toroidal pore forming model, large pores with size ranging from 3 to 10 nm are formed.26-28 The 
hydrophilic components of AMPs cover up the pore surface to create a hydrophilic channels 
resulting in leakage of cytoplasmic material. The reorientation of hydrophilic phospholipid head 
groups on the surface of pores have also been proposed.25 In contrast with the toroidal model, the 
barrel-stave pore formation model involves certain peptide-peptide interactions to create smaller 
1-2 nm in diameter pores.29-32 In this model, the phospholipid head groups do not reorient and the 
surface of the transmembrane pores are lined up by the AMPs alone, thus creating a hydrophilic 
channel. Both of these models create transmembrane pores leading to leakage of intercellular 
material and breakdown of membrane potential resulting in the bacterial cell death. 
Alternatively, non-pore formation mechanisms of bacterial cell membrane rupture by AMPs have 
been proposed.23, 33 At high concentration of peptides relative to membrane phospholipids, AMPs 
can lie parallel to the membrane surface and form carpets leading to formation of very large size 
(> 20 nm) defects. 23, 33 “Detergent” or “solubilization” mechanisms in which drastic collapse of 





1.3 Synthetic polymers as mimics of antimicrobial peptides 
Even though highly selective antibacterial activity and hindered development of bacterial 
resistance toward AMPs have made them attractive candidates for therapeutic applications, but the 
large scale application of AMPs face several hurdles.17 The synthesis or isolation of AMPs from 
living organisms would be a very expensive and time-consuming process.12, 34,35 Furthermore, the 
oral administration of AMPs would be challenging due to proteolysis, which would drastically 
reduce the bioavailability of AMPs.34,35 Intravenous delivery of AMPs will hamper the large scale 
implementation of AMPs as antibiotic drugs.17 Thus, research efforts have been focused in the last 
decade to obtain synthetic mimics of AMPs, which could be readily synthesized and share the 
fundamental design features of AMPs. A Majority of AMPs have a secondary α-helical 
structure.36-37 These α-helical amphiphilic peptides adopt a “facially amphiphilic” segregated 
structures, while interacting with bacterial cell membrane, in which cationic and hydrophobic 
subunits adopt opposite faces of the helix.37-41 Such a segregated amphiphilic structure has been 
considered vital for the antibacterial activity of AMPs, and initial research endeavors were focused 
to emulate the α-helical features of AMPs.38, 42-43 Other studies mimicking the β-peptide structure 
demonstrated that highly antibacterial synthetic mimics could be obtained.43, 44 However, the role 
of secondary structures in the antibacterial activity was put to test, and it was demonstrated that 
diastereomeric peptides that were unable to form α-helical structure had potent antibacterial 
activity.45-47 Further studies revealed that overall amphiphilicity rather than the rigid secondary 
structure is the prerequisite for antibacterial activity.17, 20, 48 
The approach of amphiphilicity was extended to a range of synthetic polymers with flexible 
backbones that lacked any ability to form secondary structures, but could be produced on large 
scale due to their facile and cost effective synthesis. A range of synthetic amphiphilic polymers 
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including those based on polynorbornenes,20, 21, 49-53 polymethacrylates,54-59 poly(vinyl 
pyridines),60-64 polystyrenes,65-67 poly(vinyl alcohols),68 Nylon,69-72 urea oligomers,73-74 among 
others, have been successfully synthesized. Several studies have shown that the antibacterial 
activity of these polymers is comparable to those of natural AMPs. The lack of bacterial resistance 
development toward synthetic amphiphilic polymethacrylates was recently reported, whereas 
significant bacterial resistance was developed against conventional antibiotics in the same study.75 
1.4 Structural parameters affecting the antibacterial and hemolytic activities of synthetic 
amphiphilic polymers 
1.4.1 Polymer amphiphilicity 
Much research in the last decade on synthetic amphiphilic polymers has substantiated polymer 
amphiphilicity, the balance between cationic and hydrophobic groups, as a key structural feature 
affecting the antibacterial and hemolytic activities of synthetic polymers. Polymers with high 
cationic charge content would have higher affinity to bind with the bacterial cell membrane, but 
these polymers would have lower ability to insert through the hydrophobic core of bacterial lipid 
bilayer. On the other hand, high hydrophobic content in polymers has been shown to result in 
higher activity toward both bacteria and mammalian cells, leading to a loss of selective 
antibacterial activity.21, 55Moreover, reduction in aqueous solubility of highly hydrophobic 
polymers may lead to polymer aggregate formation.54 Formation of polymer aggregates reduces 
the effective concentration of polymers in solution, resulting in lower antibacterial activity.54 
Hence an optimum balance between cationic and hydrophobic groups is imperative to achieve 
selective antibacterial activity in synthetic amphiphilic polymers. Antibacterial activity of 
synthetic polymers has been widely assessed in terms of minimum inhibitory concentration (MIC), 
which is often described as the lowest polymer concentration of polymers required to inhibit 100% 
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(in some reports 90%) bacterial growth within a specified period of incubation (for example 6 h, 
12h, or 18 h). The toxicity of polymers toward mammalian cells has been widely evaluated by 
various researchers in terms of hemolytic activity-50% (HC50), which is the lowest polymer 
concentration resulting in hemolysis of 50% red blood cells (RBCs), within an incubation period 
of 1 hour. 
1.4.1.1 Homopolymers 
Hammond et al. described the ring opening polymerization of γ-propargyl-L-glutamate to 
synthesize amphiphilic polypeptides with quaternary ammonium and hydrophobic alkyl groups 
(Figure 1.2(a)).76 The amphiphilicity of synthetic polypeptides were optimized through variation 
in the lengths of hydrophobic tail. Polypeptide with butyl side tail was ineffective against both E. 
coli and S. aureus, but increasing the length of alkyl tail to 12 carbon atoms led to high antibacterial 
activity against S. aureus. Amphiphilic polypeptides with 6 and 8 carbons in the alkyl tail displayed 
high antibacterial activity toward E. coli. Tew and co-workers explored the antibacterial and 
hemolytic activities of “facially amphiphilic” polynorbornenes (Figure 1.2 (b)).21 “Facially 
amphiphilic” polynorbornenes have both cationic and hydrophobic groups on the same repeating 
unit. The polymer amphiphilicity was optimized through variation in alkyl tail length. A polymer 
with methyl groups had low activity against E. coli and S. aureus. Higher antibacterial activity was 
observed in a polymer with ethyl side groups. Increase in the length of side groups to propyl led 
to a substantial increase in antibacterial activity. Further increase in side group lengths resulted in 
reduction of antibacterial activity, and the polymer having long hexyl side groups was found to be 
inactive against both E. coli and S. aureus.  
An alternative approach of optimizing polymer amphiphilicity through variation of spacer arm 
distance was reported by Kuroda et al (Figure 1.2(c)).57 Cationic amphiphilic polymethacrylate 
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homopolymers with various lengths of alkyl spacer arms (distance between polymer backbone and 
cationic center) and pendent cationic centers were synthesized. The antibacterial and hemolytic 
activities of these polymers were assessed against E. coli, S. aureus, and RBCs. Homopolymers 
with 2-carbon and 4-carbon spacer arms were inactive against E. coli and moderately active toward 
S. aureus, whereas the 6-carbon spacer arm homopolymer was highly active against both E. coli 
and S. aureus. However, the 6-carbon spacer arm polymer displayed very high hemolytic activity, 
whereas the 2-carbon and 4-carbon homopolymers were non-hemolytic.  
 
Figure 1.2 a) Amphiphilic polypeptides based on γ-propargyl-L-glutamate with quaternary 
ammonium and hydrophobic alkyl groups; b) “Facially amphiphilic” polynorbornenes have both 
the cationic and hydrophobic groups on the same repeating unit; c) amphiphilic polymethacrylates 
with various lengths of spacer arms. Figures adopted from a) Hammond et al., Biomacromolecules 
2011, 12, 1666; b) Tew at al., J. Am. Chem. Soc. 2008, 130, 9836; c) Kuroda et al., 
Biomacromolecules 2012, 13, 1632. 
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1.4.1.2 Random copolymers 
Kuroda and DeGrado investigated the structure-activity relationships in cationic amphiphilic 
polymethacrylates (Figure 1.3(a)).54 Random polymethacrylate derivatives with repeating units of 
butyl methacrylate (BMA) and amine functionalized ethyl methacrylate were synthesized through 
free radical polymerization. The mole% of BMA was varied from 0% to 60%, and the MIC and 
HC50 values of copolymers were obtained. Both MIC and HC50 values of copolymers were reduced 
as the mole% of BMA was increased, signifying the effect of increased hydrophobic content of 
polymer on their membrane rupture ability. MIC value of polymers reduced till ~30 mole% of 
BMA after which no further reduction in MIC value was observed. Reduction in water solubility 
of polymers with increasing mole% of butyl methacrylate was reported. It was proposed that 
formation of aggregates in polymers with high BMA content could reduce the availability of 
polymer chains to act on bacterial cells, thus reducing their antibacterial activity.  
Palermo and Kuroda reported the synthesis of cationic polymethacrylate copolymers with methyl 
or butyl side chains at various mole ratios.55 Random copolymers with small methyl side groups 
displayed substantially lower hemolytic activity, as compared with random copolymers having 
butyl side groups. Moreover, copolymers with higher mole% content of methyl counits 
demonstrated high antibacterial activity against E. coli, resulting in highly selective antibacterial 
activity in a copolymer with 47 mole% of methyl methacrylate and 53 mole% of amine 
functionalized ethyl methacrylate repeating units. Tew et al. had also reported the reduction in 
MIC and HC50 values with increasing size of alkyl side group in “segregated” amphiphilic 
polynorbornenes (Figure 1.3(b)).52 In “segregated” approach, the amine functionalized norbornene 
comonomer was copolymerized with various hydrophobic comonomers with varying lengths of 
alkyl tails at 1:1 mole ratio. More than 3 carbon atoms in the side tail led to reduction in the 
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antibacterial activity, and highest selectivity of ~ 20 times for bacteria over RBCs was reported in 
copolymer with propyl side group. Similarly, optimization of polymer amphiphilicity through 
control of cationic and hydrophobic moieties resulted in highly selective (bacteria over RBCs) 
antibacterial activity in random Nylon-3 copolymers (β-lactams, Figure 1.3(c)).71 
 
Figure 1.3 a) Amphiphilic polymethacrylates random copolymers; b) “Segregated” amphiphilic 
polynorbornenes; c) Nylon-3 random copolymers. Figures adopted from a) Kuroda and DeGrado, 
J. Am. Chem. Soc. 2005, 127, 4128; b) Tew et al., Chem. Eur. J. 2009, 15, 433; c) Gellman et al., 
J. Am. Chem. Soc. 2007, 129, 15474. 
 
1.4.2 Molecular weight 
The molecular weight of the amphiphilic polymers is a crucial structural parameter, as it affects 
the number of bioactive moieties on each polymer chain. Generally, MIC and HC50 values are 
reported in terms of weight of polymer (usually in µg) per unit volume (mL). Thus, at same mass 
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level, a polymer with higher average molecular weight would have a smaller number of polymer 
chains as compared with a lower molecular weight polymer. Kuroda and DeGrado evaluated the 
effect of molecular weight on the antibacterial and hemolytic activities of polymethacrylate 
random copolymers.54 Higher molecular weight polymers were found to display lower solubility 
in water, in comparison with lower molecular weight polymers. The smallest polymers displayed 
the highest antibacterial activity against E. coli. Furthermore, the hemolytic activities of smaller 
polymers were significantly lower than the higher molecular weight copolymers. Mowery et al. 
reported that the MIC values of β-lactams were independent of the molecular weight, but the 
hemolytic activity increased with higher molecular weight.71 Lower molecular weight fractions 
displayed substantially lower hemolytic activity than higher molecular weight polymer fractions 
(fractions separated by dialysis).71 
In contrast to random copolymers, an increase in antibacterial activity with increase in molecular 
weight or degree of polymerization was observed in case of  amphiphilic polymethacrylate 
homopolymers.59 Similarly, synthetic amphiphilic polypeptides (homopolymers) displayed higher 
antibacterial activity at higher levels of degree of polymerization.76 “Facially amphiphilic” 
polynorbornenes, however, lost activity at higher molecular weight level (Mn ~ 10,000 g/mol) 
against S. aureus, whereas lower molecular weight polynorbornenes were highly antibacterial 
toward S. aureus.21 The formation of irreversible polyion-polyion complex formation was 
proposed as a probable reason behind this observation.21, 77 
1.4.3 Incorporation of hydrophilic poly(ethylene glycol) moieties in amphiphilic polymers 
Poly(ethylene glycol) (PEG) has been extensively used in a myriad of polymeric materials to 
impart hydrophilicity, biocompatibility, and antifouling properties.78-85 Long PEG chains 
drastically increase the hydrodynamic radius of polymers, and therefore can substantially improve 
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the pharmacokinetics of conjugated drugs.86-88 In cationic amphiphilic polymers, the inclusion of 
PEG groups may reduce the hemolytic activity of polymers through reduced hydrophobic 
interactions with RBCs. Furthermore, the improved water solubility of highly hydrophilic 
polymers may result in enhanced antibacterial activity. Youngblood et al. explored the effects of 
Peg content on the antibacterial and hemolytic activities of N-hexylated poly(vinyl pyridines) 
(Figure 1.4(a)).60-64 Random copolymers 
 
Figure 1.4 Schematic representation of hydrophilic poly(ethylene glycol) modifications in a) N-
hexylated poly(vinyl pyridines); b) amphiphilic polynorbornenes. Figures adopted from a) 
Youngblood et al., Biomacromolecules 2007, 8, 19; b) Colak et al., Biomacromolecules 2009, 10, 
353.  
having varying mole ratios of Poly(ethylene glycol) methyl ether methacrylate (PEGMA) and N-
hexylated vinyl pyridine repeating units were synthesized. PEGMA monomers with various 
lengths of Peg side chains were copolymerized with vinyl pyridine, in order to evaluate the effect 
of PEG length on biological activities of these polymers. Incorporation of just 1 mole% of 
PEGMA-1100 (Mw ~ 1100 g/mol) resulted in significant improvement of antibacterial activity, as 
compared with N-hexylated poly(vinyl pyridine) with no PEG content.61 Similar results were 
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obtained through copolymerizing hydroxyethyl methacrylate (HEMA) with vinyl pyridine. As 
compared with N-hexylated poly(vinyl pyridine), copolymer containing up to 10 mole% of HEMA 
displayed significantly higher antibacterial activity.61 These observations are interesting as PEG 
lacks any inherent antibacterial activity. The enhanced wettability of PEG containing poly(vinyl 
pyridines) was proposed as a reason behind these observations.61 Higher hydrophilicity of 
copolymers enables better interactions of polymer with aqueous bacterial assays. However, the 
reduction in hemolytic activity of these polymers was not observed until 50 mole% of PEGMA 
was incorporated into the copolymer.  
Colak et al. explored the strategy of PEGylation to improve the selectivity of amphiphilic 
polynorbornenes (Figure 1.4(b)).89 The hemolytic activity of polynorbornenes was reduced by 
increasing the PEG content, however a simultaneous deterioration in antibacterial activity was also 
reported.89 Hence, the resulting polymers demonstrated low selectivity (< 5 times) toward bacteria 
over RBCs. PEGylation was utilized to improve water solubility of amphiphilic polymethacrylates, 
which were found to be antibacterial toward a gram positive bacteria while displaying low 




Figure 1.5 Schematic representation of a) cationic amphiphilic polymethacrylates; and b) synthetic 
amphiphilic polypeptides with various types of cationic groups. Figures adopted from a) Kuroda 
et al., Biomacromolecules 2009, 10, 1416; b) Hammond et al., Biomacromolecules 2011, 12, 1666. 
1.4.4 Nature of cationic charge 
Cationic charge in AMPs originate from amine functionalized residues such as arginine and lysine. 
At physiological pH, the primary amine groups on AMPs are positively charged, 91 enabling AMPs 
to electrostatically bind with the negatively charged cell membrane of prokaryotes.8 In contrast to 
AMPs, synthetic quaternary ammonium compounds have permanently charged quaternary 
ammonium groups. Kuroda et al. investigated the role of cationic group type on the antibacterial 
and hemolytic activity of amphiphilic polymethacrylate copolymers (Figure 1.5(a)).55 A series of 
copolymers with primary, tertiary, or ammonium groups, and with varying mole ratios of 
hydrophobic and cationic groups were synthesized. Amphiphilic copolymers with primary and 
tertiary amine groups were found to be highly antibacterial against E. coli and completely inhibited 
the bacterial growth, while displaying low hemolytic activity toward RBCs.55 On the other hand, 
polymers with quaternary ammonium groups were inactive against E. coli. However, an increase 
in both antibacterial and hemolytic activity was observed after increasing the length of 
hydrophobic side groups from methyl to butyl.55 Hammond and co-workers reported similar 
observations of lack of antibacterial activity in synthetic amphiphilic polypeptides bearing 
quaternary or tertiary ammonium groups, whereas polypeptides having primary or secondary 
amine groups displayed antibacterial activity against S. aureus (Figure 1.5(b)).76 Hence, the nature 




Figure 1.6 Guanidinium containing a) amphiphilic polynorbornenes; and b) amphiphilic 
polymethacrylates. Figures adopted from a) Gabriel et al., Biomacromolecules 2008, 9, 2980; b) 
Mattheis et al., Macromol. Biosci. 2013, 13, 242. 
 
Several AMPs derive cationic charge from arginine residues bearing guanidinium groups.51 In 
comparison with amino groups, guanidinium groups are highly basic and are approximately 
completely protonated at physiological pH.92 Moreover, guanidinium groups can form hydrogen 
bonds with phospholipid head groups leading to greater binding affinity with bacterial cell 
surface.93 Gabriel and co-workers synthesized guanidinium functionalized polynorbornenes 
(Figure 1.6(a)).51 In comparison with primary amine charged polynorbornenes, Poly guanidinium 
oxanorbornenes displayed very high antibacterial activity along with low hemolytic activity. Dye 
leakage studies revealed the non-membrane rupturing mechanism of antibacterial activity. 
Intracellular targeting by these cell penetrating guanidinium polymers was proposed as a putative 
mechanism of antimicrobial activity.51 Mattheis et al. reported similar observations of higher 





1.4.5 Cationic charge density 
AL-Badri et al. investigated the role of cationic charge density on the antibacterial and hemolytic 
activities of facially amphiphilic polynorbornenes having cationic groups and hydrophobic groups 
on the same repeating unit (Figure 1.7).50 Increasing the cationic charge density led to significant 
reduction in hemolytic activity, while no adverse effect on the antibacterial activity of these 
polymers was observed. Their study showed that the cationic charge density can be utilized as an 
effective structural parameter to synthesize antibacterial but non-hemolytic synthetic amphiphilic 
polymers.50  
 
Figure 1.7 “Facially amphiphilic” polynorbornenes with varying degree of cationic charge 
density. Figure adopted from AL-Badri et al., Biomacromolecules 2008, 9, 2805. 
 
Sampson and co-workers reported the correlation between polymer backbone spacer distance and 
the biological activities of amphiphilic polymers.95 Homopolymers with backbone distance of ~ 4 
Å were inactive against bacteria or RBCs, whereas polymers with higher backbone spacer distance 
of ~ 8 Å displayed high antibacterial activity, and a simultaneous increase in hemolytic activity 
was observed.95 Thus, higher cationic charge density may reduce the hemolytic activity of 
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amphiphilic polymers, and an overall balance between charge density and polymer hydrophobicity 
can lead to polymers with selective antibacterial activity. 
1.4.6 Polymer architecture  
The antibacterial and hemolytic activities of block and random copolymers were assessed by Oda 
et al. (Figure 1.8(a)).96 At similar monomer compositions, both block and random copolymers 
displayed similar levels of antibacterial activities toward E. coli. However, the hemolytic activities 
of random copolymers were substantially higher than the block copolymers. Hence, the block 
copolymer architecture resulted in highly selective (bacteria over RBCs) antibacterial activity of 
amphiphilic copolymers.96 The dye leakage studies confirmed the membrane rupture activity of 
random and block copolymers toward vesicles mimicking the bacterial cell membrane, whereas 
only random copolymers caused dye leakage mammalian cell type lipid vesicles, confirming the 
lack of lytic ability of block copolymers toward mammalian cells. However, block copolymers 
resulted in agglutination (aggregation) of RBCs at a very low polymer concentration, as compared 
with random copolymers which caused agglutination at much higher polymer concentrations.96 
The minimum bactericidal and hemolytic concentrations were found to be orders of magnitude 
lower than the critical micelle concentrations, indicating that polymer aggregation in not required 
for antibacterial activity of these polymers.96 Similar effects of polymer architecture (random 
versus block) were reported by Wang et al. (Figure 1.8(b)).97 Oda and co-workers proposed the 
formation of intramolecular aggregates in block copolymers with the hydrophobic part of the 
copolymer at the core surrounded by the hydrophilic cationic part.96 Such intramolecular 
aggregates would reduce the hydrophobic interactions of polymers with lipid bilayer of RBCs, 





Figure 1.8 Block copolymer architecture of a) amphiphilic poly(vinyl ether)s; b) amphiphilic 
polymethacrylates. Figures adopted from a) Oda et al., Biomacromolecules 2011, 12 (10), 3581; 
b) Wang et al., Macromol. Biosci. 2011, 11, DOI: 10.1002/mabi.201100196. 
 
Intramolecular aggregates would also have enhanced the electrostatic interactions with bacterial 
cell membrane and may effectively replace the divalent cations from bacterial cell membrane, 
which are crucial for membrane integrity.98  
Sampson and co-workers synthesized alternating and random amphiphilic copolymers and 
evaluated their antibacterial and hemolytic activities.95 They reported 2 to 6 fold lower 
antibacterial activities in case of random copolymers, in comparison with alternating copolymers. 
Thus, precise locations of cationic and hydrophobic groups resulted in higher antibacterial activity. 
A random copolymer does not have consistent local balance of cationic and hydrophobic groups 







Chapter 2                              
Effect of systematic structural variations on the antibacterial and hemolytic 
activities of polyacrylates 
2.1 Introduction 
Antimicrobial agents with highly selective (bacteria over human cells) antibacterial activity and 
an ability to resist the development of bacterial resistance are urgently required. Cationic 
antimicrobial polymers have attracted significant research interest in the last decade. One of the 
major class of antimicrobial polymers is quaternary ammonium compounds (QACs), also known 
as polysurfactants.99-105 QACs attach to cell membrane of bacteria through coulombic interactions 
and the large hydrophobic groups of QACs enable their permeabilization into the hydrophobic 
core of the bacterial lipid bilayer.100 However, the high toxicity of polysurfactants toward 
mammalian cells poses a major hurdle toward their biomedical applications. The other major class 
of antibacterial polymers are synthetic amphiphilic polymers mimicking the fundamental design 
principles of natural AMPs.19, 106-108 In comparison with polysurfactants, synthetic mimics of 
AMPs have global amphiphilic nature with a distribution of amino (primary, secondary, or 
guanidinium) and hydrophobic groups throughout the length of polymer backbone. In the last 
decade, substantial research has been done to identify factors influencing the antibacterial and 
hemolytic activity of synthetic amphiphilic polymers. Mole ratio of hydrophobic moiety,52, 54, 55, 71 
length of alkyl side chain,76, 21 molecular weight,21, 54, 59, 71, 76 polymer architecture,96, 97 and identity 
of amine functionality51, 55, 76, 94 have been found to play significant roles in the antibacterial and 
hemolytic activity of synthetic amphiphilic polymers.  
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Kuroda and DeGrado described the synthesis and biological activities of cationic amphiphilic 
polymethacrylates.54 The random copolymers of cationic and hydrophobic (butyl side group) 
counits displayed high activity against E. coli, but were found to be highly hemolytic toward 
human RBCs.54 On the other hand, cationic polymethacrylate homopolymer of amine 
functionalized monomer did not display hemolytic or antibacterial activity (for E. coli).54 As 
hydrophobic groups facilitate the insertion of polymers into hydrophobic lipid bilayer of bacteria,17 
homopolymers without hydrophobic counits may not readily penetrate through the bacterial cell 
surface, leading to lower antibacterial activity of homopolymers, as compared with random 
copolymers. It can be reasonably expected that by increasing the hydrophobicity of 
polymethacrylate homopolymers, their antibacterial activity could be improved, and due to high 
charge density (presence of cationic charge on each counit) in homopolymers, they may display 
low toxicity toward mammalian cells. To this end, we synthesized a selection of polyacrylate 
homopolymers with varying lengths of the hydrophobic alkyl tail from methyl to butyl, in order to 
optimize the biological activities of these homopolymers.109 Each homopolymer was synthesized 
at two molecular weight level to explore the effect of polymer size on their biological activities. 
Random copolymers were synthesized to compare their biological activities with similar 
homopolymers. We synthesized polymers with an acrylate backbone instead of methacrylate, as 
the higher chain flexibility of acrylate polymers, due to lack of methyl group at polymer backbone 
could lead to a greater degree of freedom for side groups resulting in higher membrane 
permeabilization ability. 
Our investigation revealed that amphiphilic polyacrylate homopolymers can show highly selective 
activity toward bacteria over RBCs, whereas random copolymers were found to be extremely 





(Methylamino)ethanol, 2-(Ethylamino)ethanol, 2-(Propylamino)ethanol2, 2-(Butylamino)ethanol, 
dichloromethane (anhydrous), N,N-diisopropylethylamine, acetonitrile (anhydrous), AIBN, 
methyl 3-mercaptopropionate, 1-hexanol, cyclohexanol, 3,3-Dimethyl-2-butanol, hexane, and 
diethyl ether were purchased from Sigma-Aldrich and used without further purification. Acryloyl 
chloride from Sigma-Aldrich was distilled prior to use. Butyl acrylate was stirred with inhibitor 
remover packing for 20 minutes and filtered before use. Di-tert-butyl dicarbonate and 
trifluoroacetic acid were purchased from VWR. 
2.2.2 Instrumentation 
1H NMR spectra were obtained on 300 MHz and 600 MHz Varian NMR spectrometers using 
CDCl3 or DMSO-d6 as solvents. Molecular weights (Mw and Mn) of Boc protected polymers, and 
their molecular weight distributions (Mw/Mn, PDI) were obtained on Waters alliance GPCV 2000 
using linear polystyrene as standard. Tetrahydrofuran (HPLC grade) was used as eluent with a 
flow rate of 1 mL/min. OD600 was obtained to measure bacterial growth on an Agilent 8453 
spectrophotometer (using 1 cm path length plastic cuvette). OD595 and OD414 were obtained on a 







2.2.3 Synthesis of 2-(N-Boc-alkylamino)ethanols110 
Scheme 2.1 Synthesis of N-Boc protected alklyamino ethanols 
 
Di-tert-butyl dicarbonate (26 g, 119 mmol) was added in a 250 mL single neck round bottom flask, 
already charged with 2-(Methylamino)ethanol (8.6 mL, 108 mmol) and H2O (110 mL). The 
reaction mixture was then stirred at 34 oC for 6 hours. After 6 hours, reaction mixture was extracted 
with ethyl acetate (3*125 mL), dried with sodium sulfate, and ethyl acetate was evaporated under 
reduced pressure to yield pure product (90 % yield). 1H NMR (300 MHz, CDCl3): δ 1.45 (s, 9H), 
2.92 (s, 3H), 3.38 (s, 2H), 3.73 (s, 2H). 
For Boc protection of 2-(Ethylamino)ethanol, 2-(Propylamino)ethanol, and 2-
(Butylamino)ethanol, higher reaction time (1-2 days) and slightly modified work-up procedure 
was employed. After the completion of reaction, organic and aqueous layers were separated. Ethyl 
acetate (30 mL) was added into organic layer, and washed with distilled water (3*125 mL). 
Organic layer was dried over sodium sulfate, and excess solvent removed using rotavapor to yield 
pure product. 2-(N-Boc-ethylamino)ethanol: 1H NMR (300 MHz, CDCl3): δ 1.13 (t, 3H), 1.48 (s, 
9H), 3.18-3.46 (d, 4H), 3.75 (s, 2H); 2-(N-Boc-propylamino)ethanol: 1H NMR (300 MHz, 
CDCl3): δ 0.91 (t, 3H), 1.45-1.62 (bs, 11H), 3.2 (s, 2H), 3.4 (s, 2H), 3.77 (s, 2H); 2-(N-Boc-
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butylamino)ethanol: 1H NMR (300 MHz, CDCl3): δ 0.92 (t, 3H), 1.29 (m, 2H), 1.38-1.6 (bs, 
11H), 3.21 (s, 2H), 3.37 (s, 2H), 3.71 (s, 2H). 
2.2.4 Synthesis of amine functionalized monomers.54 
Scheme 2.2 Synthesis of amine functionalized acrylate monomers 
 
2-(N-Boc-butylamino)ethanol (12.84 g, 60 mmol) was added in a 500 mL, 3 neck round bottom 
flask, loaded with  N,N-diisopropylethylamine (17.4 mL, 100 mmol) and dichloromethane (100 
mL). Acryloyl chloride (5.52 mL, 68 mmol) was then added drop wise at 0 oC, under nitrogen 
atmosphere. The reaction mixture was allowed to warm to room temperature and stirred overnight. 
After 18 hours, reaction mixture was washed with distilled water (3 times), 10% citric acid (2 
times), 10% potassium carbonate (2 times), and saturated sodium bicarbonate solution (3 times). 
Organic layer was separated and dried over sodium sulfate followed by removal of excess solvent 
using rotavapor. The resultant liquid was purified by silica gel column chromatography using 
hexane/ethyl acetate (1:1) as eluent. 60% yield (Monomer 4). 1H NMR (300 MHz, CDCl3): δ 0.92 
(t, 3H), 1.30 (m, 2H), 1.48 (bs, 11H), 3.23 (s, 2H), 3.48 (s, 2H), 4.3 (s, 2H), 5.86 (d, 1H), 6.14 (m, 
1H), 6.43 (d, 1H). Similar procedure was followed for the synthesis of all other monomers. 
Monomer 1 (R=Methyl): 1H NMR (600 MHz, CDCl3): 1.41 (s, 9H), 2.88 (s, 3H), 3.48 (s, 2H), 
4.23 (s, 2H), 5.81 (d, 1H), 6.09 (q, 1H), 6.38 (d, 1H); Monomer 2 (R=Ethyl): 1H NMR (600 MHz, 
CDCl3): 1.11 (t, 3H), 1.45 (s, 9H), 3.3 (s, 2H), 3.5 (s, 2H), 4.3 (s, 2H), 5.9 (d, 1H), 6.14 (q, 1H), 
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6.4 (d, 1H); Monomer 3 (R=Propyl): 1H NMR (600 MHz, CDCl3): 0.86 (t, 3H), 1.39-1.59 (bs, 
11H), 3.19 (s, 2H), 3.47 (s, 2H), 4.25 (s, 2H), 5.84 (d, 1H), 6.12 (q, 1H), 6.4 (d, 1H); Monomer 5 
(R=H): 1H NMR (600 MHz, CDCl3): 1.50 (s, 9H), 3.47 (t, 2H), 4.27 (t, 2H), 4.83 (s, 1H), 5.93 (d, 
1H), 6.15 (q, 1H), 6.45 (d, 1H); Monomer 6 (R=n-Hexyl):  1H NMR (600 MHz, CDCl3): 0.86 (t, 
3H), 1.28 (m, 4H), 1.34 (m, 2H), 1.63 (m, 2H), 4.11 (t, 2H), 5.77 (d, 1H), 6.08 (q, 1H), 6.35 (d, 
1H); Monomer 7 (R=Cyclohexyl): 1H NMR (600 MHz, CDCl3): 1.18-1.56 (m, 6H), 1.71 (m, 
2H), 1.85 (m, 2H), 4.81 (m, 1H), 5.76 (dd, 1H), 6.08 (q, 1H), 6.35 (dd, 1H); Monomer 8 (R=2,2,3-
Trimethylbutyl): 1H NMR (600 MHz, CDCl3): 0.95 (s, 9H), 1.19 (d, 3H), 4.78 (q, 1H), 5.81 (d, 
1H), 6.13 (q, 1H), 6.40 (d, 1H). 
2.2.5 Synthesis of polyacrylate homopolymers.54 
Scheme 2.3 Synthesis of amine functionalized polyacrylate homopolymers 
 
As per literature, a 3 neck 100 mL flask was charged with Monomer 2 (2.25 g, 9.25 mmol), AIBN 
(15.2 mg), Methyl-3-mercaptopropionate (MMP, 0.205 mL), and Acetonitrile (10 mL). The 
reaction mixture was degassed with dry nitrogen for 5 minutes, and stirred at 65 oC for 18 hours. 
Acetonitrile was evaporated using rotavapor, and small amount (1 mL) of dichloromethane was 
added into reaction mixture, followed by precipitation into hexane (2 times). Resultant polymer 
was dried under reduced pressure. By varying the mole ratios of MMP and monomer, two series 
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of molecular weights were obtained (Mw of approximately 6000 g/mol and 1600 g/mol). 
1H NMR 
(300 MHz, CDCl3) is as shown in Figure 2.1(a). 
For the deprotection of Boc protecting group, Polybutyl was dissolved in minimum quantity of 
dichloromethane, and excess quantity of trifluoroacetic acid (TFA) was added. The mixture was 
stirred for 4 hours at room temperature. TFA was removed under reduced pressure, followed by 
distillation using methanol (3×40 mL) and Dichloromethane (3×40 mL). Small quantity of 
acetonitrile (2 mL) was added, and mixture was repeatedly precipitated into diethyl ether to obtain 
amphiphilic polymers. Polymers were dried under reduced pressure and lyophilized. Complete 
deprotection of amine groups was confirmed from 1H NMR spectra (Figure 2.1(b)).  
 
Figure 2.1 1H NMR spectrum of a) Polyethyl_1.6K before Boc deprotection (300 MHz, CDCl3); 
b) Polyethyl_1.6k after Boc deprotection with TFA (300 MHz, CDCl3); c) Polypropyl_1.6k before 
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Boc deprotection (600 MHz, CDCl3); and d) Polypropyl_1.6k after Boc deprotection with 
TFA(600 MHz, CDCl3).  
2.2.6 Synthesis of random copolymers.54 
Scheme 2.4 Synthesis of polyacrylate random copolymers 
 
For the synthesis of copolybutyl_6K, butyl acrylate (3.1 g, 24.2 mmol) was charged into a 100 
mL, 3 neck round bottom flask, loaded with Monomer 5 (N-(tert-butoxycarbonyl)aminoethyl 
acrylate, 5.21 g, 24.2 mmol), AIBN (0.08 g), MMP (0.268 mL), and acetonitrile (49 mL). The 
reaction mixture was purged with dry nitrogen for 5 minutes and stirred at 65 oC for 18 hours. 
Acetonitrile was evaporated and copolymer was re-dissolved in 2 mL dichloromethane, followed 
by repeated precipitation in hexane. For the synthesis of Copoly1, Copoly2, and Copoly3; higher 
mole percentage (60%) of Monomer 5 was used to facilitate the solubility of copolymers in 
aqueous medium. Deprotection of Boc protected copolymers was carried out as explained above. 
Relative percentage of monomers in copolymers were confirmed with 1H NMR spectra and found 
to be in agreement with the monomer feed ratio. 
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Figure 2.2 1H NMR (300 MHz, DMSO-d6) spectrum of the Copolybutyl_6k random copolymer.   
2.2.7 Calculation of Degree of polymerization 
Figure 2.3 represents the 1H NMR spectrum of Polymethyl_6K. A broad single peak at δ 2.9-3.1 
(integral value =57.33) belongs to methyl protons in the monomer repeat unit. A single peak at δ 
3.68 belongs to methyl proton at the polymer end chain (integral value=3). Degree of 
polymerization (DP) of polymer is calculated as below: 
D. P. = (57.33/3) + (3/3)   
D. P. = 20.11 




Figure 2.3 1H NMR spectrum (300 MHz, CDCl3) of Polymethyl_6K homopolymer.  
2.2.8 Preparation of Polymer dilutions for antibacterial and hemolysis testing 
Stock solution (20 mg/mL) for each polymer was prepared by dissolving in DMSO or in deionized 
water. Serial dilutions (2 fold) and some intermediate concentrations (14.3 mg/mL, 7.14 mg/mL, 
and 3.85 mg/mL) were then obtained by further adding distilled water. As described in the 
antibacterial testing protocol below, a tenfold dilution would further take place in the 96 well assay 
plates. Control solutions (without polymers) were prepared in a similar way by diluting DMSO 
with deionized water.  
2.2.9 Antibacterial Test.54 
Polymers were dissolved in DMSO to prepare stock solutions (20 mg/mL). Subsequent serial 
dilutions were prepared by adding water. Control solutions without polymers were similarly 
prepared. An aliquot of E. coli (TOP 10, ampicillin resistant) was incubated in Luria Bertani (LB) 
broth (containing ampicillin, 100 µg/mL) overnight at 37 oC. To measure bacterial cell growth, 
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turbidity as optical density at λ=600 nm (OD600) was obtained on an Agilent 8453 
spectrophotometer using a disposable plastic cuvette with 1 cm path length. This cell culture was 
diluted with fresh LB broth to obtain a cell suspension with OD600 = 0.1 and incubated for 
approximately 1.5 h at 37 oC. After approximately 1.5 h, the OD600 of cell culture increased from 
0.1 to 0.45-0.5, indicating a log-phase growth. This cell suspension was further diluted with fresh 
LB broth to obtain the final stock suspension of bacteria with OD600 = 0.001. Polymer solution (10 
µL) or control solutions were added in triplicate to each well of a 96 well cell culture plate (REF 
353916, BD falcon, flat bottom) followed by the addition of E. coli stock suspension (90 µL), and 
culture plates were incubated at 37 oC for 18 h. Bacterial growth was measured as turbidity at 
OD595 on a SpectraMax 340 PC micro plate reader. Minimum Inhibitory Concentration (MIC) was 
defined as the lowest polymer concentration resulting in 100% inhibition of bacterial growth. MIC 
values reported here are the averages of three separate experiments performed on different days. 
Antibacterial activities of polymers against S. aureus (ATCC 25923) were similarly obtained, 
except Mueller-Hinton (MH) broth was used in place of LB broth.  
2.2.10 Hemolysis Test54 
Red blood cells were obtained by centrifuging the freshly drawn mouse blood at 3000 rpm for 15 
minutes. Plasma and white blood cells were removed as supernatant, and RBCs were washed with 
TBS buffer (Tris, 10mM, 150 mM NaCl, pH=7) multiple times. I ml of RBCs were diluted with 9 
mL of TBS buffer. This RBCs suspension was further diluted by a factor of 40 by adding TBS to 
obtain the final RBCs stock suspension (0.25% RBCs). RBCs stock suspension (120 µL), polymer 
or control solutions (15 µL), and TBS (15 µL) were added into 600 µL micro centrifuge tubes, and 
incubated at 37 oC for 1 h. After 1 h, the tubes were centrifuged at 4000 rpm for 5 minutes. 
Supernatant (30 µL) was added into each well of a 96 well cell culture plate (in triplicate). 
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Hemoglobin concentration was measured as OD414. HC50 value was defined as the lowest polymer 
concentration required to lyse 50% of RBCs within an incubation period of 1 h. 1% triton X-100 
was used as a reference for 100% hemolysis. HC50 values reported in this study are the averages 
of three separate experiments. Percentage hemolysis for each polymer concentration was 
calculated using the following formula:  
% 𝐻𝑒𝑚𝑜𝑙𝑦𝑠𝑖𝑠 =   (
𝑂𝐷414𝑃𝑜𝑙𝑦𝑚𝑒𝑟 − 𝑂𝐷414𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙
𝑂𝐷414𝑇𝑟𝑖𝑡𝑜𝑛 − 𝑂𝐷414𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝐶𝑜𝑛𝑡𝑟𝑜𝑙
) × 100 
2.3 Results and discussion 
2.3.1 Synthesis of polymers 
Polyacrylate homopolymers were synthesized by free radical polymerization of N-Boc protected 
monomers (Scheme 2.3). Likewise, N-(tert-butoxycarbonyl)aminoethyl acrylate was 
copolymerized with butyl acrylate (1:1, feed mole ratio, Scheme 2.4) to synthesize random 
copolymers in order to explore the effect of polymer architecture (homopolymer verses random 
copolymer) on the biological activities of amphiphilic polyacrylates.  In amphiphilic polyacrylate 
homopolymers, the hydrophobic alkyl tail is directly attached to the cationic center, whereas in 
random copolymer the cationic group and alkyl side chains are present on separate repeating units. 
Thus, due to the difference in polymer architecture, homopolymers and random copolymers may 
display significantly different biological activities. Two series of molecular weights (Mw ~ 6k 
g/mol (DP~6) and 1.6 g/mol (DP~22)) were synthesized for each homopolymer and random 
copolymer. Data from 1H NMR (600 MHz or 300 MHz) were used to estimate the degree of 
polymerization (D.P.) of products and to confirm the complete deprotection of the Boc group. Gel 
permeation chromatography (linear polystyrene standards) was employed to estimate molecular 
weights and polydispersity (PDI) of precursor polymers (Table 2.1). Polymethyl_6k represents the 
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homopolymer with methyl chain attached to amine group and having a molecular weight (Mw) of 
approximately 6k g/mol. The nomenclature Copolybutyl_6k is used for the random copolymer 
with molecular weight (GPC) of approximately 6k g/mol. Scheme 2.4 represents the synthesis of 
copolymers designed to discern the effect of hydrophobic side chain shape on antibacterial and 
hemolytic activity of amphiphilic copolymers. Mole percentage (in feed) of hydrophobic 
comonomer was kept at 40%, because the higher mole% of hydrophobic monomer could result in 
low solubility of copolymers in aqueous assay mediums. 
 








































































































2.3.2 Antibacterial activity of polymers against E. coli 
The antibacterial activity of polymers was obtained against gram negative E. coli in terms of 
minimum inhibitory concentrations (MIC), and is shown in Table 2.2 and Figures 2.4-2.5. 
Polymethyl_6k, with methyl tail attached to cationic center, displayed very low antibacterial 
activity against E. coli (MIC = 1048 µg/mL). Increasing the length of alkyl tail from methyl to 
ethyl (Polyethyl_6k) did not significantly increase the antibacterial activity against E. coli. 
Similarly, Polypropyl_6k in which the propyl tail attached to the cationic center, displayed low 
antibacterial activity (MIC = 810 µg/mL) against E. coli. Further increase in the length of the alkyl 
tail from propyl to butyl led to an increase in antibacterial activity. Polybutyl_6k, with a butyl 
chain linked to cationic center displayed moderate antibacterial activity against E. coli (MIC = 417 
µg/mL). These observations indicate that the increase in the length of alkyl tail (attached to cationic 
center) from methyl to butyl in our homopolymers (6k series) does not substantially affect the 
antibacterial activity of these polymers against E. coli. In comparison with homopolymers, the 
random copolymer Copolybutyl_6k demonstrated high antibacterial activity against E. coli (MIC 
= 13 µg/mL). In copolybutyl, the cationic charges and hydrophobic butyl side chains are present 
on separate repeating units or counits, in contrast with Polybutyl_6k homopolymer, in which 
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Figure 2.4 Minimum inhibitory concentrations of 6k g/mol series polymers toward E. coli  
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The effect of reduction in polymer molecular weight on the antibacterial activity of these polymers 
against E. coli is apparent from Figure 2.5. As compared with the slightly antibacterial 6k series 
homopolymers (D.P. ~ 23), 1.6k series homopolymers (D.P. ~ 6) did not display antibacterial 
activity against E. coli till the highest polymer concentration tested (MIC >2000 µg/mL). Hence, 
there is a significant effect of molecular weight on the antibacterial activity of the polyacrylate 
homopolymers described here. In contrary to homopolymers, we did not observe the effect of 
molecular weight on the antibacterial activity of random copolymers at the levels of molecular 
weight tested in this study. The lower molecular weight random copolymer, Copolybutyl_1.6k, 
displayed high antibacterial activity (MIC = 13 µg/mL) toward E. coli, similar to its higher 
molecular weight counterpart Copolybutyl_6k.  
Cationic amphiphilic polymers are believed to rupture the bacterial cell membrane through 
electrostatic and hydrophobic interactions.17, 21, 59 The presence of the hydrophobic alkyl tail 
directly on the cationic center may sterically hinder the electrostatic interactions of the cationic 
group with the negatively charged phospholipid head groups in cell membrane of E. coli, thus 
leading to low antibacterial activity in polyacrylate homopolymers. Moreover, the presence of 
cationic charge along with hydrophobic alkyl tail on each counit may hinder the penetration of 
amphiphilic homopolymers through the hydrophobic core of bacterial lipid bilayer. In random 
copolymers, the cationic groups and hydrophobic alkyl tails are located on separate counits, thus 
the cationic charges and hydrophobic groups in the random copolymers can effectively interact 
with the anionic cell membrane of E. coli. The high charge density in polyacrylate homopolymers 
may also be one of the reasons for their lower antibacterial activity for E. coli.50 Sampson and 
coworkers recently reported that homopolymers with smaller spatial distance (~4 Å) between 
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cationic centers displayed lower antibacterial activity, as compared with homopolymers with 
higher (8-10 Å) backbone distance between cationic centers.95   
Kuroda et al. recently reported the effect of hydrophobic alkyl spacer arm (distance from polymer 
backbone to cationic center) lengths on the antibacterial and hemolytic activities of 
polymethacrylate homopolymers.57 Whereas the homopolymer with a 2-carbon spacer arm had 
low activity against E. coli, a homopolymer with a 6-carbon linear spacer arm displayed very high 
antibacterial activity and hemolytic activity. The effect of longer spacer arm resulting in higher 
antibacterial activity was attributed to the snorkel effect in which the cationic center can attach to 
the anionic lipid head groups of bacterial cell membrane and the long hydrophobic spacer arm 
could extend through the hydrophobic core of lipid bilayer.57 
2.3.3 Antibacterial activity of polymers against S. aureus 
Antibacterial activity of polymers were obtained in terms of MIC against S. aureus, and are as 
shown in Figures 2.6 - 2.7 and Table 2.2. Significantly, all 6k series homopolymers displayed high 
antibacterial activity against S. aureus (MIC = 62 µg/mL), irrespective of the length of the alkyl 
tail (methyl to butyl) attached to cationic center. Polymethyl_6k with the shortest alkyl tail in this 
series of polymers displayed high activity against S. aureus, even though it was not found to be 
active against E. coli. Copolybutyl_6k having cationic and hydrophobic groups on separate counits 




Figure 2.6 Minimum Inhibitory Concentrations of 6k g/mol series polymers toward S. aureus  
 
Figure 2.7 Minimum Inhibitory Concentrations of 1.6k g/mol series polymers toward S. aureus  







































































































































antibacterial activity against S. aureus (MIC = 34 µg/mL). The similar antibacterial activity of 
polyacrylate homopolymers and random copolymer against S. aureus is in contrast with their 
activity against E. coli, in which the random copolymer, Copolybutyl_6k, displayed high 
antibacterial activity, whereas the homopolymers were significantly less active against E. coli. 
Significant dissemblance in the cell wall structure of S. aureus and E. coli is a plausible reason 
behind higher activity of homopolymers against S. aureus than E. coli.49, 111, 112 In E. coli, a thin (8 
nm) negatively charged peptidoglycan layer is sandwiched between an outer membrane 
(lipopolysaccharides) and an inner cytoplasmic membrane. In comparison with this double 
membrane structure of E. coli, S. aureus has only a single plasma membrane (cytoplasmic) 
surrounded by a much thicker (15-80 nm) negatively charged peptidoglycan layer (murein layer). 
Therefore, the double membrane structure of E. coli is more difficult to rupture or penetrate than 
the single membrane structure of S. aureus. Moreover, the presence of large number of cationic 
charges in the homopolymer would favor columbic interactions with the thick negatively charged 
murein layer of S. aureus. The random copolymer, Copolybutyl_6k, did not show this selectivity 
between the two classes of bacteria and is highly potent against both E. coli and S. aureus. 
The activities of lower molecular weight (~1.6k g/mol) polymers towards S. aureus are as shown 
in Figure 2.7 and Table 2.2. Polymethyl_1.6k and Polyethyl_1.6k did not show antibacterial 
activity against S. aureus (MIC > 2000 µg/mL). Further increase in alkyl tail length to propyl and 
butyl led to increase in antibacterial activity. Polybutyl_1.6k displayed a high antibacterial 
bacterial against S. aureus (MIC = 62 µg/mL), which is similar to the activity of its higher 
molecular weight counterpart Polybutyl_6k. This is in contrast with the activity of homopolymers 
against E. coli, as all 1.6k series homopolymers were inactive (MIC > 2000 µg/mL), whereas 6k 
series homopolymers showed moderate activity against E. coli. This observation further 
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corroborates the higher activity of these homopolymers against gram positive S. aureus, as 
compared with gram negative E. coli. The random copolymer Copolybutyl_1.6k, manifested high 
activity against S. aureus (MIC = 18 µg/mL). Hence, the random copolymers at both 1.6k g/mol 
and 6k g/mol molecular weight levels have high antibacterial activity toward both S. aureus and 
E. coli, whereas homopolymers in general show an increase in antibacterial activity with higher 
molecular weight. 
2.3.4 Hemolytic activity of polymers 
The toxicity of polymers toward mammalian cells were assessed in terms of hemolytic 
concentration-50% (HC50), which is the lowest polymer concentration required to lyse 50% of 
RBCs within an incubation period of 1 h. Our study found that majority of our homopolymers are 
non-hemolytic (HC50 >2000 µg/mL, Figures 2.8 - 2.9), whereas random copolymers were highly 
hemolytic against RBCs. Hemolytic activity of Polybutyl_6K is 36 times lower than the random 
copolymer, copolybutyl_6k. Cell membranes of RBCs lack the net negative charge, and hemolytic 
activity of amphiphilic polymers primarily arises from the hydrophobic interactions of polymers 
with RBCs’ cell membrane.17, 21, 54 Higher hydrophobicity of polymers increases the ability of the 
polymers to permeate into the hydrophobic domain of lipid bilayer, leading to high hemolytic 
activity. The high cationic charge density in homopolymers would reduce the overall 
hydrophobicity of the homopolymers, and the presence of a cationic group along with every alkyl 
side tail in homopolymers would not favor hydrophobic interactions of homopolymers with the 
lipid bilayer of RBCs. However, in random copolymers (Scheme 2.4), cationic charges and 
hydrophobic alkyl side groups are placed on separate repeat units, and thus side groups can readily 




Figure 2.8 Hemolytic activity (HC50) of 6k g/mol series polymers against RBCs 
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propyl to butyl led to marked increase in hemolytic activity. Therefore, three carbon atoms in the 
alkyl tail is the threshold for hydrophobicity, above which these homopolymers have higher 
hemolytic activity. Such a dramatic increase in hemolytic activity by increasing the length of alkyl 
tail from 3 to 4 carbon atoms has been reported by Sen and coworkers.113 
2.3.5 Selectivity of polymers 
The selectivity of polymers toward bacteria over RBCs is defined as the ratio of hemolytic activity, 
HC50, to minimum inhibitory concentration, MIC, of polymers. High selectivity of polymers 
toward bacteria over mammalian cells is desired for therapeutic applications of polymers. All 
homopolymers in 6k g/mol series displayed selective activity toward bacteria over RBCs (Figure 
2.10 and Table 2.2). However, homopolymers demonstrated lower selectivity for E. coli over 
RBCs, in comparison with selectivity toward S. aureus over RBCs. Among homopolymers, 
Polypropyl_6k showed the highest selectivity of >2.5 times toward E. coli over RBCs. All 
homopolymers in 6k g/mol series, except Polybutyl_6k, displayed a high selectivity of >32 times 
toward S. aureus over RBCs. Polybutyl_6k due to its high hemolytic activity (HC50 = 253 µg/mL) 
has the lower selectivity of 4.1 times for S. aureus over RBCs. Moreover, all homopolymers in 6k 
g/mol series were more selective towards S. aureus than E. coli. We found Polymethyl_6k to be 
17 times more active against S. aureus over E. coli. Hence, the polyacrylate homopolymers 
reported here are doubly selective; i.e. selective for bacteria over RBCs, and selective for one type 
of bacteria over other. As apparent from Figures 2.10 - 2.11 and Table 2.2, random copolymers 
have highly potent antibacterial and hemolytic activity, and thus lack selectivity for bacteria over 
RBCs. The lack of selectivity of random copolymers may limit their practical applications. We 





Figure 2.10 Biological activity (MIC and HC50) of 6k g/mol series polymers. 
 














































































































































2.3.6 Effect of alkyl side group shape on the biological activities of random copolymers 
The pertinence of the role of the hydrophobic side chain on optimizing the antimicrobial and 
hemolytic activity amphiphilic copolymers has been well established,17, 20, 71, 76 but the role of the 
hydrophobic side chain shape on antibacterial and hemolytic activity of random copolymers has 
not been explored, to the best of our knowledge. To this end, we synthesized polyacrylate random 
copolymers having different shapes of hydrophobic alkyl chain while keeping the same number of 
carbon atoms in side chain. Copoly1—6K, Copoly2—6K, and Copoly3—6K were synthesized 
(Scheme 2.4) to explore the role of the hydrophobic side chain shape on biological activity of 
SMAMPs. As evident from the data compiled in Figure 2.12 and Table 2.2, all three copolymers 
exhibited similar antibacterial activities against E. coli and S. aureus. Hence, we did not observe 
any effect of shape of alkyl side chain on antibacterial activity of amphiphilic copolymers. 
Copoly2_6K and Coploly3_6K were highly hemolytic (HC50<7 µg/mL), whereas slightly lower 
hemolytic activity in case of Copoly1_6K (HC50 = 26 µg/mL) was observed.  
Figure 2.12 Biological activity (MIC and HC50) of random copolymers with various shapes of 

































In conclusion, the position of the hydrophobic alkyl side group with respect to the cationic center 
has substantial effect on the antibacterial and hemolytic activity of amphiphilic polymers. In the 
“same centered” homopolymers, the presence of the alkyl tail on the cationic center resulted in 
selective activity toward S. aureus over RBCs and S. aureus over E. coli. We found that the 
molecular weight of our polymers has a significant effect on their antibacterial activities. Higher 
molecular weight homopolymers demonstrated higher antibacterial activity in comparison with 
lower molecular weight homopolymers. In contrary to homopolymers, “separate center” random 
copolymers having alkyl side groups and cationic centers separately on different repeating units 
displayed high antibacterial and hemolytic activity, leading to non-selective antibacterial activity. 
Random copolymer displayed similar antibacterial activity at the molecular weight levels 
investigated in this study. The role of shape of hydrophobic alkyl side groups was investigated. We 
observed that the biological activity of random polyacrylate copolymers described here does not 











Synthesis of Cationic Amphiphilic Polyacrylates with Superior Bactericidal 
Activity and Concomitant Low Hemolytic Activity120 
3.1 Introduction 
One of the major challenges toward therapeutic applications of synthetic amphiphilic polymers is 
their toxicity to mammalian cells. The biocompatibility of synthetic polymers has been widely 
assessed in terms of hemolytic activity toward red blood cells (RBCs). Some of the factors 
affecting the hemolytic activity of synthetic amphiphilic polymers have been recently explored. 
Compared with random copolymers, block copolymer architecture can show lower toxicity toward 
RBCs.96, 97 “Same centered” polymers, having an alkyl tail attached to their cationic center, 
demonstrated lower hemolytic activity in comparison with “separate center” copolymers.109, 113 
Incorporation of hydrophilic poly(ethylene glycol) side groups reduced hemolytic activity in N-
hexylated poly(vinyl pyridines).60-63 Mole ratios and size of hydrophobic groups were varied to 
optimize the antibacterial and hemolytic activity of polymers.52, 54, 55, 71, 76, 113  
In chapter 2, we reported that amphiphilic polyacrylates with 2-carbon spacer arms and various 
lengths of alkyl tail attached to the cationic center have low hemolytic activity and high activity 
against S. aureus. Kuroda and coworkers recently reported an amine functionalized 
polymethacrylate homopolymer with a 6-carbon linear spacer arm to be highly active against both 
E. coli and S. aureus.57 However, the hemolytic activity of this polymer was also extremely high, 
and it did not display selectivity toward bacteria over RBCs.57 Thus, by copolymerizing a longer 
spacer arm monomer with a short spacer arm monomer, copolymers with high antibacterial activity 
and lower hemolytic activity could be expected. The “snorkel effect” 114-117from longer spacer arms 
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in which the cationic charges attach to the bacterial cell membrane and the long alkyl spacer arms 
can extend through the hydrophobic core of lipid bilayer may lead to high antibacterial activity, 
whereas the high cationic charge density and lower hydrophobicity of short spacer arms lower the 
hemolytic ability of polymers. 
Here we report the synthesis of highly antibacterial but selective (bacteria over RBCs) 
polyacrylates by copolymerization of a monomer (M2) having a 2-carbon spacer arm (distance 
from polymer backbone to cationic center) with a 6-carbon spacer arm monomer (M6), in varying 
mole ratios (Scheme 3.3). All copolymers in the range of 10 to 90 mole% of M6 displayed highly 
selective activity toward bacteria over RBCs. A copolymer having 90 mole% of M6 demonstrated 
208 times more selectivity towards E. coli over RBCs (Table 3.2 and Figure 3.6).  
3.2 Experimental 
3.2.1 Materials 
2-(Methylamino)ethanol, methyl 3-mercaptopropionate (MMP), acetonitrile (anhydrous), N,N-
diisopropylethylamine, 2,2’-Azobis(2-methylpropionitrile) (AIBN), tetrahydrofuran (THF), and 
6-Amino-1-hexanol were purchased from Sigma-Aldrich and used without further purification. 
Acryloyl chloride was purchased from Sigma-Aldrich and distilled prior to use.  Di-tert-butyl 
dicarbonate, trifluoroacetic acid, hexane, and diethyl ether were purchased from Alfa Aesar and 
used as received.  Dichloromethane and ethyl acetate were purchased from BDH. All other 






1H and 13C NMR spectra of polymers were obtained on a Varian Unity NMR spectrometer (600 
MHz) using CDCl3 or DMSO-d6 as solvents. Molecular weights and polydispersities (PDI) of Boc-
protected polymers were estimated on an EcoSec HLC-83220 gel permeation chromatography 
instrument (RI detector) using linear polystyrene standards and THF as eluent. Bacterial growth 
in E. coli and S. aureus assays were determined by measuring turbidity as optical density at λ=600 
nm (OD600), on an Agilent 8453 spectrophotometer using  1 cm path length plastic cuvette. 
SpectraMax 340 PC micro plate reader from Molecular Devices was used to measure OD595 
(Antibacterial test) and OD414 (Hemolysis test).  
3.2.3 Synthesis of N-Boc protected 6-hexanol-1-amine57 
Scheme 3.1 Synthesis of tert-butyl (6-hydroxyhexyl)carbamate. 
 
9.16 g (42 mmol) di-tert-butyldicarbonate in 20 mL THF was added drop wise to a 250 mL round 
bottom flask already charged with 4.92 g (42 mmol) 6-hexanol-1-amine, 30 mL THF, and 50 mL 
1M NaOH. The biphasic reaction mixture was stirred at room temperature for 24 hours. The 
reaction mixture was extracted with ethyl acetate, and subsequently washed with water and 
saturated sodium bicarbonate solution. The resulting organic layer was dried with sodium sulfate, 
and solvent was evaporated using a Rotavapor. 60% yield. 1H NMR (600 MHz, CDCl3): δ 1.26-
1.38 (m, 4H), 1.39-1.43 (s, 9H), 1.43-1.48 (m, 2H), 1.50-1.57 (m, 2H), 3.08 (t, 2H), 3.6 (t, 2H).  
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3.2.4 Synthesis of 6-((tert-butoxycarbonyl)amino)hexyl acrylate (Monomer M6)57  
Scheme 3.2 Synthesis of 6-((tert-butoxycarbonyl)amino)hexyl acrylate. 
 
N-Boc protected 6-hexanol-1-amine (5 g, 23 mmol), triethyl amine (4 mL), and dichloromethane 
(50 mL) were added into a 100 mL round bottom flask. The flask was sealed with septa and 
reaction mixture was purged with nitrogen (using a stainless steel needle) for 5 minutes. A solution 
of acryloyl chloride (5 mL, 23 mmol) in 5mL dichloromethane was added drop-wise to the reaction 
mixture at 0 oC. The reaction mixture was allowed to warm to room temperature and stirred 
overnight, followed by washing with distilled water and saturated sodium bicarbonate solution. 
The organic layer was dried with sodium sulfate and solvent was evaporated using a Rotavapor. 
The resultant liquid was purified by silica gel chromatography using 9:1 hexane/ethyl acetate as 
eluent. 60% yield. 1H NMR (600 MHz, CDCl3): δ 1.28-1.36 (m, 4H), 1.37-1.42 (s, 9H), 1.42-1.48 
(m, 2H), 1.63 (m, 2H), 3.06 (s, 2H), 4.10 (t, 2H), 5.77 (dd, 1H), 6.07 (q, 1H), 6.35 (dd, 1H). 13C 
NMR (151 MHz, CDCl3): δ 25.6, 26.35, 28.37, 28.49, 29.93, 40.39, 64.42, 78.95, 128.51, 130.50, 
156, and 166.26. 
3.2.5 Synthesis of 2-((tert-butoxycarbonyl)methylamino)ethyl acrylate (Monomer M2) 
Monomer M2 was synthesized as described in Chapter 2. 
49 
 
3.2.6 Synthesis of amphiphilic Polymers 
Scheme 3.3 Synthesis of polymers with 2- and 6-carbon spacer arm distance from polymer 
backbone to charge center. 
 
Homopolymers and random copolymers were synthesized using a slightly modified literature 
procedure.54 Monomer M6 (0.814 g, 3 mmol) and Monomer M2 (0.688 g, 3 mmol) were added 
into a 100 mL round bottom flask containing AIBN (9.85 mg), MMP (33.2 µL), and 6 mL 
acetonitrile (anhydrous). The flask was sealed with septa and the reaction mixture was purged with 
nitrogen (using a stainless steel needle) for 5 minutes, followed by stirring at 65 oC for 18 hours. 
Solvent was then evaporated under reduced pressure, and polymer was re-dissolved in 2 mL THF 
and precipitated in hexane twice. The resulting polymer was dissolved in excess trifluoroacetic 
acid and left under stirring for 3 hours. TFA was removed under reduced pressure and polymer 
was dissolved in methanol and precipitated in diethyl ether 3 times. The resulting polymer was 
kept under vacuum for 3 days and lyophilized. 1H NMR (600 MHz, D2O): δ 1.19-1.33 (bs, 53H), 
1.41-2.45 (bm, 131H), 2.56 (s, 2H), 2.62-2.72 (bs, 42H), 2.81-2.89 (bs, 26H), 3.20-3.31 (bs, 24H), 
3.57 (s, 3H), 3.84-4.05 (26H), 4.10-4.33 (24H). 1H NMR of all other cationic amphiphilic polymers 




3.2.7 Antibacterial and hemolytic activity of polymers 
Antibacterial activity of polymers in terms of Minimum Inhibitory Concentrations (MIC) and 
hemolytic activity of polymers in terms of HC50 were obtained as described in Chapter 2.  
3.2.8 Field-Emission Scanning Electron Microscopy Analysis (FESEM) of bacterial 
membrane disruption118 (a), 119 
Bacteria (E. coli and S. aureus) were cultured in nutrient media (LB broth for E. coli and MH broth 
for S. aureus) at 37 oC for 24 h. 1 mL of bacterial suspension was dissolved in 9 mL fresh nutrient 
broth and incubated at 37 oC to obtain bacterial cell suspension in log phase growth (OD600 = 0.45 
to 0.5). This cell suspension was further diluted with fresh nutrient broth to obtain a final cell 
suspension with OD600 = 0.1 (~ 10
8 CFU/mL). 900 µL of this cell suspension was added into 100 
µL aqueous solution of PM6-90% (6 ×MIC), followed by incubation at 37 oC for 2 h under 
constant shaking (200 rpm). Untreated cell suspension (without polymer) was used as a control. 
Bacteria were obtained by centrifuging the suspension at 12000 rpm for 2 minutes. Cells were 
washed with PBS (twice), and fixed by treating with glutaraldehyde (2.5%) for 60 minutes. Cells 
were then washed with deionized water, and sequentially dehydrated with 30, 50, 70, 80, 90, and 
100% aqueous ethanol solutions. The dehydrated cells were dried at room temperature for two 
days before being mounted on a carbon tape. The samples were sputter coated with Au/Pd (60:40). 
SEM analysis was performed on an AMRAY 1910 Field Emission Scanning Microscope at an 
operating voltage of 5 kV.  
3.2.9 Time dependent killing efficiency study of polymer toward E. coli119 
Bacteria (E. coli) were cultured in nutrient broth overnight. This cell suspension was diluted with 
fresh nutrient broth and incubated at 37 oC for a period of approximately 1.5 h to achieve log-
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phase growth (OD600 ~ 0.5). Cell culture in log-phase growth was further diluted with fresh nutrient 
broth to obtain stock cell suspension with OD600 = 0.001 (~ 10
5 CFU/mL). This stock cell 
suspension was treated with polymers at two concentrations (1×MIC and 2×MIC), and bacterial 
cell suspension without polymer treatment was used as a control. Bacterial samples were taken out 
at regular time intervals (0 h, 1 h, 2 h, 4 h, 6 h, and 8 h), and were serially diluted using several 10 
fold dilutions. 20 µL of final cell dilution was streaked on to an Agar plate for incubation at 37 0C 
for 24 h, followed by counting of Colony Forming Units (CFU).  
3.3 Results and Discussion120 
3.3.1 Synthesis of polymers 
We synthesized a series of polyacrylate random copolymers via free radical copolymerization of a 
monomer having a 2- carbon spacer arm (M2), with a 6-carbon spacer arm monomer (M6). AIBN 
was used as an initiator and methyl 3- mercaptopropionate was used as a chain transfer agent for 
molecular weight control. The mole % (in feed) of M6 was increased in steps of 10%, giving 
polymers with compositions that closely match the feed mole% (Table 3.1). Our synthetic 
approach was expected to result in random copolymers of M2 and M6, rather than the 
homopolymers of M2 and M6, because M2 and M6 are both acrylate monomers with similar 
structures and can be expected to have similar monomer reactivity ratios (r) close to 1, leading to 
the formation of copolymers with random counit placement. For example, glycidyl acrylate (r = 
1.18) and 2-ethylhexyl acrylate (r = 1.12) have similar monomer reactivity ratios close to 1 for free 
radical copolymerization.118(b) The mole ratios found in our resulting copolymers are close to the 
feed mole ratios of monomers over the entire range of polymer compositions, including the cases 
of PM6-10% and PM6-90% after 18 h of reaction time (Table 3.1). Thus, the homopolymerization 
of one of the two comonomers is not likely. The molecular weights of precursor copolymers, before 
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deprotection with TFA, were estimated using Gel Permeation Chromatography. The average 
degree of polymerization (DP) of polymers was obtained from 1H NMR, using end group analysis. 
The DP of all polymers was found to be in close proximity of 30. PM6-x%, denotes the cationic 
amphiphilic copolymer having x mole% (in feed) of M6 monomer.  
Table 3.1 Characterization of polymers 
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Figure 3.1 Graph showing that the actual mole % of M6 counits in the copolymers closely 
matches the feed mole % of M6 monomer 
3.3.1.1 Determination of degree of polymerization and actual mole percentage of repeating 
units in polymer 
Figure 3.2 1H NMR spectrum of PM6-50% (600 MHz, D2O). 
In Figure 3.2, a single peak at δ 3.57 belongs to the methyl protons (q) at chain end. A broad 
single peak at δ 3.84-4.05 (f) belongs to methylene protons in M6 monomer repeat unit. 
Methylene protons in M2 monomer repeat unit (k) give a chemical shift at δ 4.10-4.33. Degree of 
polymerization of polymer is calculated as below: 
Degree of Polymerization = [(25.98/2) + (24.29/2)]/ (3/3) = 25 
Mole % of M6 repeat units: 25.98/ (25.98+24.29) = 52% 
Mole % of M2 repeat units: 24.29/ (25.98+24.29) = 48% 
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3.3.1.2 Calculation of ratio of rate of chain transfer to rate of propagating chain coupling 
Due to high rate constant for termination by coupling (~106 L/mol/s),118(b) coupling between 
propagating species is possible resulting in two methyl esters per chain. However, in our case we 
expect chain transfer to dominate (>97%) due to: the very low concentration of propagating species 
in free radical polymerization (~10-6 M); high rate constant for chain transfer of acrylates to MMP 
(~1.6× 103 L/mol/s using chain transfer constant as 2 and rate constant for propagation as 800 
L/mol/s);118(b) as well as high concentration of chain transfer agent (5×10-2 M) used in our polymer 
synthesis. A conservative estimate of the ratio of rate of chain transfer to chain coupling is at least 
~ 45 (i.e. 
𝑅𝑎𝑡𝑒 𝑜𝑓 𝐶ℎ𝑎𝑖𝑛 𝑇𝑟𝑎𝑛𝑠𝑓𝑒𝑟
𝑅𝑎𝑡𝑒 𝑜𝑓 𝐶ℎ𝑎𝑖𝑛 𝐶𝑜𝑢𝑝𝑙𝑖𝑛𝑔
 = 
10−6 × 0.05×1.6× 103
10−6 × 10−6 × 106
 = 45.4) 
 
3.3.2 Antibacterial activity of polymers toward E. coli 
The antibacterial activities of polymers were determined in terms of minimum inhibitory 
concentration (MIC) against E. coli. MIC is defined as the minimum polymer concentration 
required to inhibit 100% bacterial growth after an incubation period of 18 h. As is apparent from 
Figure 3.3 and Table 3.2, MIC values of polymers reduced substantially as the mole % of M6 was 
increased in the polymers. Whereas a homopolymer of 2-carbon spacer arm monomer M2, PM6-
0%, did not display antibacterial activity against E. coli, incorporation of just 20 mole % of M6 
monomer led to substantial (~ 6 times) decrease in MIC value. Further reduction in MIC value was 
observed with increasing the mole % of M6 monomer. PM6-90% and PM6-100% demonstrated 
the lowest MIC values against E. coli in our series of polymers. Sampson et al. reported the effect 
of backbone spacer distance between attach points of side groups (having pendent cationic 
charge).95 Homopolymers 11 and 12 with a smaller backbone spacer arm distance between cationic 
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centers (~ 4 Å) lacked antibacterial activity, whereas homopolymers 13 and 14 with higher 
backbone spacer arm distance (~ 8 Å) displayed high antibacterial activity.95 It was reported that 
the charge density in homopolymers 11 and 12 could be too high to cause bacterial killing, hence 
a higher backbone spacer distance (hydrophobic spacer) of 4 Å to 8 Å is required for antibacterial 
activity in that polymer system. However, the increase in backbone spacer distance led to increase 
in hemolytic activity also. Whereas homopolymers 11 and 12 were found to be non-hemolytic 
(HC50 > 2000 µg/mL), homopolymers 13 and 14 showed high hemolytic activity (HC50 = 379 
µg/mL and 443 µg/mL). Our approach of copolymerizing the 2-carbon spacer arm monomer M2 
with the 6-carbon spacer arm monomer M6, changes the spatial charge distribution in polymer, 
even though the backbone spacer distance remains the same thus reducing the overall charge 
density in the polymer. As both cationic charge and hydrophobic groups are required in the 
polymer to  


































































































Figure 3.3 Minimum inhibitory concentrations of polymers toward E. coli  
 
permeate and disrupt the bacterial cell membrane, a balance is required between cationic and 
hydrophobic groups in the polymers. PM6-0% with a short 2-carbon spacer arm has a higher 
charge density and less hydrophobicity thus reducing its ability to penetrate through the 
hydrophobic core of the lipid bilayer. High charge density and small distance between cationic 
charges may restrain the conformational freedom of side groups, thus affecting the lipid bilayer 
permeability of the polymers. Incorporation of the 6-carbon spacer arm monomer M6 with its long 
hydrophobic spacer arm increases the overall hydrophobicity of polymer. Addition of M6 also 
increases the distance between cationic groups on adjacent repeating units, thus reducing the 
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3.3.3 Antibacterial activity of polymers toward S. aureus 
Antibacterial activities of polymers in terms of MIC were determined against the gram positive S. 
aureus (ATCC 25923) and are as shown in Table 3.2 and Figure 3.4. All polymers in this series 
displayed high antibacterial activity against S. aureus. The homopolymer of M2, PM6-0%, 
manifested an MIC of 104 µg/mL toward S. aureus, whereas PM6-0% was found to be inactive 
against E. coli (MIC = 1428 µg/mL). The effect of increasing monomer M6 mole% on the 
antibacterial activity of polymers toward S. aureus was less pronounced as compared with E. coli 
(Table 3.2 and Figure 3.3). We did not observe substantial increase in antibacterial activity against 
S. aureus till incorporating 50 mole% of M6 monomer. Compared with the MIC values of PM6-
0%, PM6-90% displayed 7 times lower MIC value against S. aureus, and 183 times lower MIC 
value against E. coli.  
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3.3.4 Hemolytic activity of polymers toward mouse red blood cells (RBCs) 
Hemolytic activities of polymers were determined in terms of hemolytic concentration – 50% 
(HC50), which is the minimum polymer concentration resulting in 50% lyses of mouse RBCs 
within an incubation period of 1 hour. HC50 values of polymers are as shown in Table 3.2 and 
Figure 3.5. Significantly, all polymers, except PM6-100%, displayed very low hemolytic against 
RBCs. In comparison with extremely hemolytic PM6-100%, polymer PM6-90% (HC50 = 1619 
µg/mL) was found to be approximately 850 times less hemolytic toward RBCs, even though its 
antibacterial activities are similar to PM6-100%. We found that majority of our polymers have 
HC50 value in excess of 2000 µg/mL, which is the highest polymer concentration tested in this 
study.  
RBCs’ cell membrane consists of zwitterionic phospholipid head groups, and thus lacks net 
negative charge on its outer surface. Amphiphilic polymers can penetrate the RBCs’ cytoplasmic 
membrane through hydrophobic interactions. The observation that all of our polymers in the range 
of PM6-0% to PM6-90% are non-hemolytic but PM6-100% is highly hemolytic, indicates that 
even a small mole% of the shorter spacer arm counits (~3 per chain) can prevent the insertion of 
these polymers into lipid bilayer of RBCs. Monomer M6 has a long hydrophobic spacer arm, and 
increasing the mole% of M6 should have inevitably led to a rapid increase in hemolytic activity. 
Incorporation of 20-30 mole% of hydrophobic monomer in polymers was reported to drastically 
increase the hemolytic activity of polymers.54, 55, 59 In our polymers, the presence of positive charge 
on each counit and a combination of longer and shorter cationic spacer arms led to high 




Figure 3.5 Hemolytic activity of polymers toward mouse red blood cells 
 
3.3.5 Selectivity of polymers 
The selectivity of a polymer toward bacteria over RBCs is defined in terms of the ratio of hemolytic 
activity to minimum inhibitory concentration of the polymer (HC50 / MIC). The selectivity of 
polymers toward bacteria over RBCs is apparent from Figure 3.6 and Table 3.2. PM6-100% was 
highly antibacterial as well as hemolytic, whereas PM6-90% was found to be 208 times more 
selective toward E. coli over RBCs, and 108 times selective toward S. aureus over RBCs. PM6-
80% is >133 times selective toward E. coli over RBCs and >80 times more selective toward S. 
aureus over RBCs. Both polymers displayed high antibacterial activity similar to PM6-100%. All 
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A majority of these polymers displayed doubly selective antibacterial activity i.e. bacteria over 
RBCs and one type of bacteria over another. Polymer containing 0 to 60 mole% of M6 monomer 
displayed selective antibacterial activity against S. aureus over E. coli. PM6-0%, a homopolymer 
of M2, is inactive against E. coli, but it displayed high activity against S. aureus. Significant 
differences in the cell envelope structure of gram negative E. coli and gram positive S. aureus may 
be a probable reason behind this observation.49, 111, 112 The double membrane structure of the gram 
negative E. coli is more difficult to penetrate than the single membrane structure of the gram 
positive S. aureus. Furthermore, S. aureus has a 15-80 nm thick negatively charged murein layer 
(peptidoglycans) covering the lipid bilayer; whereas E. coli has a thin 6 nm thick peptidoglycan 
layer, sandwiched between the outer and inner membranes. This may result in higher coulombic 





Figure 3.6 Biological activity (MIC and HC50) of polymers  
 
 




























3.3.6 Scanning electron microscopy analysis of bacterial membrane disruption 
The MIC assay does not distinguish between the bacteriostatic (growth inhibiting) and bactericidal 
(killing) ability of polymers. Also, MIC assay does not provide details about the mechanism of 
antibacterial action of amphiphilic polymers. The membrane rupturing mechanism of antibacterial 
action of our polymers was confirmed using the FE-SEM analysis. E. coli and S. aureus were 
treated with 6×MIC concentration of polymers for 2 hours. The cell morphologies of bacterial 
cells treated with polymers were analyzed using SEM. Bacterial cells without polymer treatment 
were used as controls. As shown in Figure 3.8, control E. coli cells (without polymer treatment) 
showed intact cell surface morphologies. Similarly, control S. aureus cells show no damage to the 
cell surface (Figure 3.10). As evident from Figure 3.9, E. coli treated with PM6-90% displayed 
severe damage and rupture of the cell surface. Most of the E. coli cells were covered with cell 
lysate and the rod shaped morphology of E. coli was not recognizable. Similar results were 
obtained after treating E. coli with PM6-60% and PM6-30% (Figures 3.12 and 3.14), confirming 
that these polymers disrupt and rupture the cell membrane of bacteria.  
Figures 3.11, 3.13, and 3.15 show the S. aureus treated with polymers PM6-100%, PM6-60%, and 
PM6-30%, respectively. Similar to our observation in case of E. coli, S. aureus cells treated with 








Figure 3.8 FE-SEM image of E. coli cells without polymer treatment (control) show intact cell 
surface morphology 
 
Figure 3.9 FE-SEM image of E. coli cells treated with PM6-90% show severe damage and 






Figure 3.10 FE-SEM image of S. aureus cells without polymer treatment (control) show intact 
cell surface morphology 
 
Figure 3.11 FE-SEM image of S. aureus cells treated with PM6-90% show severe damage and 






Figure 3.12 FE-SEM image of E. coli cells treated with PM6-60% show severe damage and 
rupture of bacterial cell surface 
 
Figure 3.13 FE-SEM image of S. aureus cells treated with PM6-60% show severe damage and 






Figure 3.14 FE-SEM image of E. coli cells treated with PM6-30% show severe damage and 
rupture of bacterial cell surface 
 
 
Figure 3.15 FE-SEM image of S. aureus cells treated with PM6-30% show severe damage and 




3.3.7 Time dependent killing efficiency study of polymer PM6-90% against E. coli 
In order to further explore the bactericidal ability of these polymers, PM6-90%, the polymer with 
highest selectivity toward E. coli over RBCs in this series, was used as a representative polymer. 
E. coli at an initial concentration of ~ 105 CFU/mL were treated with PM6-90% for various time 
intervals. Within 2 hours of incubation, more than 90% of bacterial colony forming units were 
found to be killed (Table 3.3 and Figure 3.16). At both 1 × MIC and 2 × MIC concentrations of 
PM6-90%, 100% killing of bacterial colony forming units was observed within an incubation 
period of 6 hours. This 5-log reduction in bacterial CFUs within few hours of incubation with 
PM6-90% demonstrates the highly potent bactericidal ability of these polymers. This test also 
confirmed that the minimum bactericidal concentration i.e. the minimum polymer concentration 
to result in 100% killing of bacterial CFUs is equal to the MIC value of PM6-90%.  
Table 3.3 Time-dependent killing efficiency of PM6-90% toward E. coli. Viable cells (CFU/mL) 












E. coli (CFU/mL) 







     6.0 × 104 
3.0 × 104 
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6 × 102 
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nil 
2.3 × 104 
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Figure 3.16 Time-dependent killing efficiency curve of PM6-90% against E. coli 
 
 
Figure 3.17 Confirmation of bactericidal activity of PM6-90% against E. coli at various time 
intervals using Agar plate assay. The final polymers concentration was equal to 1×MIC. E. coli 
without polymer treatment was used as positive control and is shown in a) at 1 h, b) at 6 h time 



































In conclusion, we have synthesized cationic amphiphilic acrylic random copolymers having 2- and 
6-carbon spacer arm counits as antibacterial agents. These amphiphilic copolymers (DP ~ 30) 
displayed superior antibacterial activities with concomitant low hemolytic effect. The 
homopolymer with a 6-carbon spacer arm (PM6-100%) has high cell membrane disruption ability 
and is non-selective (high antibacterial and hemolytic activity). Incorporation of a 2-carbon spacer 
arm counits in the copolymers resulted in highly selective antibacterial activity. We found that 
with just 10 mole% of M2 counits, PM6-90% polymer displayed drastically reduced hemolytic 
activity, by a factor of 850, without serious deterioration of antibacterial activity, in comparison 
with highly hemolytic PM6-100% homopolymer. Unlike the case of strong electrostatic 
interactions between the negatively charged cell surface of bacteria and cationic polymers, the 
selectivity of cationic amphiphilic polymers toward bacteria over RBCs may arise from the weaker 
electrostatic interactions between cationic polymers and zwitterionic lipid head groups of the RBC 
membrane. Incorporation of only three M2 counits into a chain with DP of ~30 can significantly 
impact the conformation of the polymer during the process of membrane rupture. M2 with a four 
carbon shorter hydrophobic spacer arm than M6, can lead to a level of polymer conformation with 
fewer degrees of freedom, thus substantially reducing the “snorkel effect” of a longer spacer arm 
of the copolymer. This copolymer system represents one of the most promising systems in 
synthetic polymeric antibacterial agents. The control of spacer arm lengths and copolymer 
composition can serve as one of the effective structural parameters in the synthesis of polymers 





3.5 1H NMR spectra of cationic amphiphilic polymers 
 
Figure 3.18 1H NMR spectrum of polymer PM6-0% (600 MHz, D2O) 
 
 




Figure 3.20 1H NMR spectrum of polymer PM6-20% (600 MHz, D2O) 
 
 




Figure 3.22 1H NMR spectrum of polymer PM6-40% (600 MHz, D2O) 
 
 




Figure 3.24 1H NMR spectrum of polymer PM6-60% (600 MHz, D2O) 
 
 




Figure 3.26 1H NMR spectrum of polymer PM6-80% (600 MHz, D2O) 
 
 

















3.6 Gel Permeation Chromatography curves of precursor polymers (before Boc 
deprotection) 
 
















Effect of Incorporating Non-ionic Hydrophilic Poly(ethylene glycol) Counits on 
the Biological Activities of Amphiphilic Polymers Having 6-carbon Spacer Arm 
Counits as Bioactive Component 
4.1 Introduction 
In chapter 3, we described the synthesis of highly antibacterial but non-hemolytic polyacrylates 
through copolymerization of a 6-carbon spacer arm amphiphilic monomer with a 2-carbon spacer 
arm amphiphilic monomer.120 Whereas the homopolymer of M6 was highly hemolytic and 
antibacterial, a random copolymer with just 10 mole% of M2 displayed dramatically lower 
hemolytic activity than the M6 homopolymer while maintaining similar antibacterial activity, 
resulting in a greater than 200 fold selectivity toward E. coli over RBCs. As compared with these 
copolymers of M6 and M2, in which every repeating unit bears a cationic charge, copolymers of 
M6 and non-ionic counits with hydrophilic poly(ethylene glycol) (PEG) side groups may be 
expected to show selective (bacteria over RBCs) antibacterial activity (Scheme 4.1). In contrast 
with short cationic M2 counits, incorporation of monomers with long (~ 12 to 57 atoms) 
hydrophilic PEG side groups may lead to considerably different biological activity. Biocompatible 
linear PEG polymers are FDA-approved for internal consumption and are known to exert 
protective effect on RBCs.78-82, 121-122 Long hydrophilic PEG side groups would have highly 
extended confirmation in an aqueous environment and may reduce hydrophobic interactions of 
polymers with the RBC lipid bilayer.86-88, 122 
Hydrophilic PEGs have been widely used to improve biocompatibility and hydrophilicity in a 
myriad of polymeric materials.78-85 Youngblood et al. reported the improvement in 
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biocompatibility of N-hexylated poly(vinyl pyridines) through incorporation of Poly(ethylene 
glycol)methyl ether methacrylate (PEGMA) monomers with various lengths of PEG side groups.62 
Colak et al. reported the reduction in hemolytic activity through incorporation of non-ionic and 
hydrophilic repeat units in amphiphilic polynorbornenes, but the antibacterial activity of 
PEGylated polynorbornenes reduced drastically with increasing content of PEG, resulting in very 
low selectivity values (< 5).89 PEGylated polymethacrylates were found to be antibacterial toward 
a gram positive bacteria while displaying low hemolytic activity.90 In our present study, as 
compared with  
Scheme 4.1 a) Synthesis of cationic amphiphilic polymers. b) Biological activity of PM6 polymers 





highly hemolytic PM6-100, the copolymerization of the appropriate mole % of non-ionic 
hydrophilic PEGMA monomer led to substantial reduction in hemolytic activity of polymers 
resulting in highly selective antibacterial activity. 
In this chapter, we describe the antibacterial and hemolytic activities of amphiphilic polymers 
synthesized by copolymerizing a 6-carbon spacer arm monomer M6 with the hydrophilic and 
biocompatible PEGMA monomers. Our strategy of copolymerizing counits having cationic and 
hydrophobic spacer arm with non-ionic hydrophilic monomers resulted in polymers with as high 
as >100 times selectivity toward E. coli over RBCs (Table 4.2). Similar to our previous findings, 
copolymerization of M6 with a small mole% of PEGMA resulted in significant reduction in 
hemolytic   activity of polymers, but to a lesser extent. We also observed an abrupt increase in 
antibacterial activity of these polymers at certain mole%’s of PEGMA monomers (Figures 4.1, 
4.2, and Table 4.2), rather than a gradual increase in antibacterial activity as previously reported 
for the case of copolymers of M6 and M2. Moreover, PEGMA copolymers displayed higher 
antibacterial activity toward gram negative E. coli over gram positive S. aureus, which is in 
contrary to copolymers of M6 and M2. The bactericidal activities of these copolymers were 
confirmed by time-kill studies, and Field Emission Scanning Electron Microscopy (FE-SEM) 
analysis ascertained the membrane disruption mechanism of antibacterial activity of copolymers 
reported here.  
4.2 Experimental 
4.2.1 Materials  
Methyl 3-mercaptopropionate (MMP), acetonitrile (anhydrous), N, N-diisopropylethylamine, 2, 
2’-Azobis(2-methylpropionitrile) (AIBN), tetrahydrofuran (THF),  and 6-amino-1-hexanol were 
purchased from Sigma-Aldrich and used without further purification. Poly(ethylene glycol) methyl 
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ether methacrylates (Mn ~ 300 and 950) was purchased from Sigma-Aldrich and were treated with 
inhibitor remover prior to use. Acryloyl chloride was purchased from Sigma-Aldrich and distilled 
prior to use.  Di-tert-butyl dicarbonate (t-Boc), trifluoroacetic acid (TFA), hexane, and diethyl 
ether were purchased from Alfa Aesar and used as received.  Dichloromethane and ethyl acetate 
were purchased from BDH. All other chemicals or reagents were used as obtained without further 
purification. 
4.2.2 Instrumentation 
1H and 13C NMR spectra of monomers and polymers were obtained on a Varian Unity NMR 
spectrometer (600 MHz) using CDCl3 or D2O as solvents. Molecular weights and polydispersities 
(PDI) of precursor polymers (Boc protected) were estimated on an EcoSec HLC-83220 gel 
permeation chromatography instrument (RI detector) using linear polystyrene standards and THF 
as eluent. Bacterial growth in E. coli and S. aureus assays was determined by measuring the 
turbidity as optical density at λ=600 nm (OD600), on an Agilent 8453 spectrophotometer using  1 
cm path length plastic cuvette. A SpectraMax 340 PC micro plate reader from Molecular Devices 
was used to measure OD595 (Antibacterial test) and OD414 (Hemolysis test). Scanning electron 
microscopy images were obtained on an AMRAY 1910 field emission scanning microscope at an 
operating voltage of 5 kV. 
4.2.3 Synthesis of tert-butyl (6-hydroxyhexyl)carbamate and 6-((tert-
butoxycarbonyl)amino)hexyl acrylate (monomer M6)120 
Boc protected hexanolamine (tert-butyl (6-hydroxyhexyl)carbamate) and monomer M6 (6-((tert-






4.2.4 Synthesis of polymers 





0.9 g (3 mmol) poly(ethylene glycol) methyl ether methacrylate (Mn~ 300) and 0.814 g (3 mmol) 
Monomer M6 were added to a 100 mL round bottom flask containing 9.85 mg (0.06 mmol) AIBN, 
33.3 µL MMP, and 6 mL anhydrous acetonitrile. The flask was sealed and purged with nitrogen 
for 5 minutes. The reaction mixture was stirred at 65 0C for 18 h. Acetonitrile was evaporated 
using a rotavapor and the polymer was re-dissolved in THF and repeatedly precipitated in hexane. 
The molecular weight of the polymer was estimated using GPC. The resultant polymer was 
dissolved in excess TFA and left under stirring for 4 hours. TFA was removed under reduced 
pressure and polymers was dissolved in methanol and repeatedly precipitated in diethyl ether. The 
polymer was kept under vacuum for 2 days to remove solvent traces followed by lyophilization. 
Yield 0.82 g. 1H NMR (600 MHz, D2O): δ 0.63-1.12 (bm, 33H), 1.15-2.48 (bm, 134H), 2.67-2.77 
(s, 2H), 2.79-2.92 (bs, 20H), 2.92-3.1 (bm, 2H), 3.2-3.35 (bs, 30H), 3.38-3.75 (bm, 153H), 3.77-





4.2.5 Antibacterial and hemolytic activity of polymers 
Antibacterial activity of polymers in terms of Minimum Inhibitory Concentrations (MIC) and 
hemolytic activity of polymers in terms of HC50 were obtained as described in Chapter 2.  
4.2.6 Field-Emission Scanning Electron Microscopy (FE-SEM) analysis and time-
dependent killing efficiency studies of polymers 
The membrane disruption mechanism of antibacterial activity and time dependent killing 
efficiency studies were performed as per protocols described in Chapter 3. 
4.3 Results and Discussion 
4.3.1 Synthesis of polymers 
We synthesized a series of random copolymers via free radical polymerization of monomer 6-
((tert-butoxycarbonyl)amino)hexyl acrylate (M6) and PEGMA-300 (300 g/mol is molecular 
weight) or PEGMA-950, followed by treatment with excess trifluoroacetic acid to remove Boc 
protecting groups. The feed mole ratios of comonomers were varied from 0% to 100% in order to 
optimize the amphiphilic balance of copolymers. Actual mole ratios of comonomers in copolymers 
were confirmed using 1H NMR spectroscopy, and were found to be in close agreement with feed 
mole ratios (Table 4.1). Two series of copolymers were synthesized by copolymerizing monomer 
M6 with PEGMA-300 or PEGMA-950 in order to explore the effect of PEG side chain lengths on 
the biological activity of polymers. Due to insolubility of cationic polymers in THF, the molecular 
weights of precursor polymers (Boc protected) were estimated using GPC and found to be similar 
for all polymers (Table 4.1). Degree of polymerization (DP) of approximately 20 was targeted for 
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all polymers, because a DP of 20 had been shown to result in superior antibacterial and low 
hemolytic activities in cationic polymethacrylates. DPs of deprotected polymers (cationic charge) 
were calculated using end group analysis of 1H NMR spectra assuming chain transfer as mode of 
termination, and found to be around 20 for all polymers. Notation of PM6-X-PEG300 is used to 
represent a polymer with X mole% of M6 Monomer (feed percentage) copolymerized with 100-X 
mole % of PEGMA-300. 
 
Table 4.1 Characterization of polymers 
4.3.2 Antibacterial activity of polymers 
The antibacterial activities of polymers against E. coli (Top 10, ampicillin resistant) and S. aureus 
(ATCC 25923) were obtained in terms of Minimum Inhibitory Concentration (MIC), which is the 
lowest polymer concentration to result in 100% inhibition of bacterial growth after an incubation 




























































































































































Copolymers with up to 30 mole% of 6-carbon spacer arm counits (M6) were found to be inactive 
against bacteria. We observed an abrupt increase in antibacterial activity toward both E. coli and 
S. aureus at 50 mole% of M6 suggesting that there is an optimum mole% of M6 counits at which 
polymers display antibacterial activity. This observation is in contrast with our previous findings 
(Chapter 3) in which we observed a gradual increase in antibacterial activity with increase in 
mole% of M6 monomer. One of the reasons behind this observation may be the reduction in 
number of cationic charges and hydrophobic moieties on polymer with increasing amount of 
PEGMA, leading to lower electrostatic and lipophilic interactions between the polymers and 
negatively charged bacterial cell surface. In comparison with the homopolymers of 2-carbon 





















































































































Figure 4.1 Minimum Inhibitory Concentrations (MIC) values of polymers against E. coli as a 









Figure 4.2 Minimum Inhibitory Concentrations (MIC) values of polymers against S. aureus as a 













































S. aureus and is slightly antibacterial against E. coli, PEGMA homopolymer lacks antibacterial 
activity. Moreover, long hydrophilic PEG side groups can obstruct the interactions of M6 counits 
with the bacterial membrane in aqueous solution. This phenomena would be more effective in 
preventing M6 counit insertion into bacterial membranes at higher mole% of PEGMA-300. Thus, 
we did not observe antibacterial activity, up to the highest polymer concentration tested (2000 
µg/mL) in copolymers containing higher than 50 mole% of PEGMA-300. Increase of M6 mole% 
above 50% led to rapid increase in antibacterial activity against both E. coli and S. aureus. PM6-
90-PEG300 with 10 mole% of PEGMA-300, demonstrated similar level of activity against bacteria 
as compared with PM6-100%.  
As is apparent from Table 4.2 and Figures 4.1 and 4.2, PM6-X-PEG950 series polymers, with 
longer length of PEG side groups, displayed lower antibacterial activity in comparison with PM6-
X-PEG300 series at same mole% of PEGMA counits. Whereas PM6-50-PEG300 displayed 
significant antibacterial activity, PM6-50-PEG950 was found to be inactive against both E. coli 
and S. aureus. Also, PM6-70-PEG300 showed low MIC value toward bacteria, whereas PM6-70-
PEG950 displayed substantially higher MIC values (lower antibacterial activity). It can be 
concluded from these observations that at same mole%, shorter PEG side groups results in higher 
antibacterial activity than longer PEG side groups. 
In order to assess the effect of PEG lengths independent of the weight % (wt %) or content of 
overall PEG composition in the copolymer, we analyzed the biological activities of PM6-70-
PEG300 and PM6-90-PEG950, which have similar wt % (~43 %) or content of PEG side groups. 
As is evident from Table 4.2, we did not observe a significant difference in the antibacterial 
activities of these two polymers. Similarly, both PM6-30-PEG300 and PM6-50-PEG950, which 
have around 80 wt % PEG composition, demonstrated lack of antibacterial or hemolytic activity, 
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whereas PM6-50-PEG300 with lower wt % of PEG (64%) displayed antibacterial activity. It 
appears from these observations that overall PEG composition but not the length of PEG side 
groups affects the antibacterial activities of these polymers. 
MIC measurements and time-kill studies demonstrate that these polymers are more active against 
E. coli than S. aureus. These polymers displayed higher MIC values toward S. aureus as compared 
with E. coli. As described later in this chapter, at 2×MIC polymer concentration, > 99.9 % killing 
efficiency was achieved against E. coli after an incubation period of 8 h, but substantial S. aureus 
CFUs survived when challenged with 1×MIC concentration of polymers suggesting a higher value 
of minimum bactericidal concentration (MBC) than MIC toward S. aureus. This is in contrast with 
our previously reported polymer analogues of M6 and M2 that were in general more active against 
S. aureus than E. coli.120 Similarly, other researchers have also reported higher antibacterial 
activity of amphiphilic polymers against S. aureus than E. coli, as the double membrane structure 
of E. coli is considered more difficult to penetrate and disrupt as compared with the single 
membrane structure of S. aureus.49, 57, 123 One of the reason behind lower activity of these 
PEGylated polymers against S. aureus than E. coli, may be the significant differences in the cell 
wall structure of E. coli and S. aureus. S. aureus has up to 80 nm thick outer cell wall composed 
of negatively charged cross linked peptidoglycans (polysaccharides and amino acids). Long PEG 
side groups of polymers can make a network of hydrogen bonds with the polysaccharides in the 
bacterial cell wall, and may get stuck in the thick polysaccharide cell wall of S. aureus. In contrast 
to S. aureus, E. coli has only a 6-8 nm thick polysaccharide (peptidoglycan) layer, which is 
sandwiched between the outer cell membrane and inner cell membrane. Thus the degree of 
hydrogen bonding would be lower between these PEGylated copolymers and E. coli cell surface, 
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Figure 4.3 Schematic representation of E. coli and S. aureus cell wall and membranes. Long 
hydrophilic PEG side groups may form polyion complex through H-bonds with polysaccharides 




4.3.3 Hemolytic activity of polymers toward mouse red blood cells (RBCs) 
Hemolytic activities of polymers were obtained in terms of HC50, which is the lowest polymer 
concentration resulting in 100% lyses of red blood cells within an incubation period of 1 h (Figures 
4.4 & 4.5 and Table 4.2). As compared with the highly hemolytic PM6-100% homopolymer, PM6-
70-PEG300 with 33 mole% of PEGMA-300 counits displayed the HC50 value of 1809 µg/mL, 
which is three orders of magnitude higher than that of PM6-100%. Thus, addition of 33 mole% of 
non-ionic hydrophilic PEGMA monomer led to >950 times reduction in hemolytic activity. All 
other copolymers in the PEG300 series with higher than 30 mole% content of PEGMA did not 
show significant hemolytic activity till the highest concentration tested (HC50 >2000 µg/mL). 
Similarly, PM6-90-PEG950 with just 12 mole% PEGMA950 showed substantially lower 
hemolytic activity (HC50 = 809 µg/mL) than the PM6-100% homopolymer. Copolymers with more 
than 10 mole% of PEGMA-950 demonstrated very low hemolytic activity (HC50 >2000 µg/mL).  
These observations buttress the biocompatibility advantages of PEG side groups. In the absence 
of blood plasma, RBCs are more exposed to foreign bodies.124 Similar to blood plasma, PEG is 
believed to protect RBCs from foreign body contact.62 It has been reported that PEG may interact 
with RBC cell membrane through hydrogen bonds and weakly adsorb on the surface of RBCs, 
thus enhancing its protective effect.122 Cationic amphiphilic polymers cause hemolysis primarily 
through hydrophobic interactions. The presence of bulky hydrophilic PEG side groups would not 
favor the insertion of amphiphilic copolymers through the hydrophobic core of RBC lipid bilayer 
thus resulting in lower hemolytic activity.  
At the same mole % of PEGMA monomer, longer PEG side chains displayed lower hemolytic 
activity (Table 4.2 and Figures 4.4 &4.5). In order to assess the effect of PEG side group lengths 




Figure 4.4 Hemolytic activity of PM6-X-PEG300 series polymers against RBCs as a function of 
mole % of M6 monomer 
 
Figure 4.5 Hemolytic activity of PM6-X-PEG950 series polymers against RBCs as a function of 





































weight % or content of overall PEG composition in the polymer, we analyzed the biological 
activities of PM6-70-PEG300 and PM6-90-PEG950, which have similar wt % (~43 %) or content 
of PEG side groups. We observed a difference in the hemolytic activity of PM6-70-PEG300 and 
PM6-90-PEG950, even though both polymers have similar wt % PEG composition (~ 43 wt %, 
Table 4.1). PM6-70-PEG300 with 30 mole % of shorter PEG chains showed significantly lower 
hemolytic activity (HC50 = 1809 µg/mL) as compared with PM6-90-PEG950 (HC50 = 809 µg/mL) 
with 10 mole % of longer PEG chains. Hemolytic activity of amphiphilic polymers mainly arise 
from the hydrophobic interactions of polymers with lipid bilayer of RBCs. Shorter but spread out 
hydrophilic regions throughout the polymer backbone may deter the permeability of polymers into 
the hydrophobic domain of RBCs’ lipid bilayer, whereas in polymers with same wt % of PEG but 
longer PEG chains at lower mole %, wider regions of highly hydrophobic and hemolytic M6 
counits may exist, resulting in higher ability of these polymers to lyse the lipid bilayer of RBCs 
(Figure 4.6). This observation is in contrast with the previous report in which hemolytic activity 
of hydrophilic N-hexylated vinyl pyridine copolymers was found to be a function of total PEG 
composition and not dependent on the length of PEG side groups.62 
93 
 
Figure 4.6 Schematic representing the interactions of RBC cell membrane with polymers having 
similar wt% of PEG but different lengths of PEG side groups. 
4.3.4 Selectivity of polymers toward bacteria over RBCs 
Selectivity of polymers is defined as the ratio (HC50/MIC) of HC50 to MIC value of polymers. 
High selectivity of polymers toward bacteria over mammalian cells would be highly advantageous 
for healthcare and therapeutic applications of synthetic amphiphilic polymers. PM6-100% without 
PEG was highly antibacterial and hemolytic, and thus lacked selective (bacteria over RBCs) 
antibacterial activity, which would hamper its practical therapeutic applications. Incorporation of 
hydrophilic PEG side groups led to an increase in selectivity of these polymers. We found that 
Polymer PM6-70-PEG300 is >113 times more selective toward E. coli over RBCs and >29 times 





Figure 4.7 Antibacterial and hemolytic activities of PM6-X-PEG300 series polymers 
 





















































PEGMA-300 demonstrated >19 times selectivity toward E. coli (MIC = 104 µg/mL) over RBCs 
(HC50 > 2000 µg/mL). Similarly, PM6-90-PEG950 was found to be 31 times more selective toward 
E. coli over RBCs, and 16 times selective toward S. aureus over RBCs. However, incorporation 
of more than 50 mole% of PEGMA-300 and more than 30 mole% of PEGMA-950 monomer 
resulted in complete loss of antibacterial activity, thus leading to non-selective polymers.  
4.3.5 FE-SEM analysis of bacterial membrane disruption by polymers 
FE-SEM analysis of bacterial cell morphology was performed to ascertain the membrane 
disruption mechanism of antibacterial action of these polymers. PM6-70-PEG300 and PM6-90-
PEG950 were chosen as representative polymers as these polymers displayed the highly selective 
(bacteria over RBCs) antibacterial activity. Control E. coli and S. aureus cells, without polymer 
treatment, show intact cell surface morphologies (Figures 4.9 & 4.11). E. coli treated with PM6-
70-PEG300 and PM6-90-PEG950 show severe cell damage and surface rupture, confirming the 
cell membrane disruption mechanism of antibacterial activity (Figures 4.10 & 4.13). Similar cell 
surface damage and rupture was observed in case of S. aureus treated with PM6-70-PEG300 and 


































Figure 4.10 FE-SEM image of E. coli cells treated with PM6-70-PEG300 show severe damage 
















Figure 4.11 FE-SEM image of S. aureus cells without polymer treatment (control) show intact 













Figure 4.12 FE-SEM image of S. aureus cells treated with PM6-70-PEG300 show severe damage 
















Figure 4.13 FE-SEM image of E. coli cells treated with PM6-90-PEG950 show severe damage 













Figure 4.14 FE-SEM image of S. aureus cells treated with PM6-90-PEG950 show severe damage 




4.3.6 Time dependent killing efficiency studies of polymers 
105 CFU/mL bacterial colonies were treated with polymers for various time intervals in order to 
determine the time-dependent bacterial killing efficiency of polymers. Within 2 hours of 
incubating E. coli with PM6-70-300PEG, > 95% of bacterial colony forming units were 
eliminated. A 5 log reduction (> 99.99 % killing efficiency) in E. coli CFU/mL was achieved 
within 8 h of incubation at 2×MIC concentrations of PM6-70-PEG300 and PM6-90-PEG950 
copolymers. The time-kill studies further confirmed the bactericidal action of these polymers, 
rather than just a bacteriostatic action. As is clear from Figures 4.19 & 4.20 and Table 4.4, PM6-
70-PEG300 and PM6-90-PEG950 polymers demonstrated lower antibacterial activity against S. 
aureus, in comparison with E. coli. Whereas, 99.9% killing efficiency was achieved against E. coli 
at 1×MIC concentration of these polymers, significant percent of S. aureus cells survived even 
after 8 h incubation with polymers. This indicates that minimum bactericidal concentration is 
higher than the minimum inhibitory concentration of these polymers against S. aureus. This 
observation is in agreement with the MIC studies reported in section 4.3.2, in which higher MIC 












Table 4.3 Time-dependent killing efficiency of polymers toward E. coli. Viable cells (CFU/mL) 




Table 4.4 Time-dependent killing efficiency of polymers toward S. aureus. Viable cells 
















7.0 × 104 
1.8 × 104 
2 × 103 
5 × 102 
nil 
nil 
9.2 × 104 
1.2 × 104 




1.1 × 105 
7.7 × 104 
2.2 × 106 
6.2 × 106 
1.4 × 107 
6.4 × 107 
1.7 × 105 
1.3 × 105 
3.2 × 104 
1.0 × 104 
9.0 × 102 
nil 
6.8 × 104 
7.3 × 104 
1.5 × 104 
1.2 × 103 
nil 
nil 
1.4 × 105 
2.5 × 105 
1.2 × 106 
1.8 × 107 
1.3 × 108 











1.1 × 105 
1.7 × 105 
8.9 × 104 
6.8 × 104 
5.9 × 104 
5.2 × 104 
1.0 × 105 
1.0 × 105 
5.1 × 104 
3.0 × 104 
1.3 × 104 
nil 
1.0 × 105 
3.9 × 105 
1.9 × 106 
2.7 × 107 
3.4 × 108 
4.8 × 108 
2.1 × 105 
6.7 × 104 
4.4 × 104 
4.4 × 104 
2.0 × 104 
2.8 × 104 
1.0 × 105 
2.5 × 104 
1.8 × 103 
3.0 × 102 
2.0 × 102 
nil 
1.4 × 105 
2.5 × 105 
1.2 × 106 
1.8 × 107 
1.3 × 108 



























































Figure 4.17 Confirmation of bactericidal activity of PM6-90-PEG950 at various time intervals 
using Agar plates. The final polymer concentration was equal to MIC value. E. coli without 
polymer treatment was used as positive control and is shown in a) at 1 h, b) at 6 h time interval. 











































Figure 4.19 Confirmation of bactericidal activity of PM6-70-PEG300 against S. aureus at various 
time intervals using Agar plates. The final polymer concentration was equal to 2×MIC value. S. 
aureus without polymer treatment was used as positive control and is shown in a) at 1 h, b) at 6 h 
time interval. S. aureus treated with PM6-90-PEG950 at c) 0 h, d) 1h, e) 2 h, f) 4 h, g) 6 h, and h) 







































Figure 4.20 Time-dependent killing efficiency curve of PM6-90-PEG950 against S. aureus 
 
 
Figure 4.21 Confirmation of bactericidal activity of PM6-90-PEG950 against S. aureus at various 
time intervals using Agar plates. The final polymers concentration was equal to 2×MIC value. S. 
aureus without polymer treatment was used as positive control and is shown in a) at 1 h, b) at 8 h 
time interval. S. aureus treated with PM6-90-PEG950 at c) 0 h, d) 1h, e) 2 h, f) 4 h, g) 6 h, and h) 
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In conclusion, a series of amphiphilic copolymers manifesting antibacterial activity against E. coli 
and S. aureus were synthesized. Copolymerization of biocompatible PEGMA monomers with a 6-
carbon spacer arm amphiphilic acrylate monomer led to substantial reduction in hemolytic activity 
resulting in polymers with highly selective (bacteria over RBCs) antibacterial activity. We 
observed that the length of PEG groups appears to affect the hemolytic activity of our polymers, 
whereas only the overall wt % of PEG composition instead of the length of PEG side groups has 
effect on the antibacterial activity of these polymers. FE-SEM analysis showed severe damage to 
bacterial cell surface morphology confirming the cell membrane disruption mechanism of 
antibacterial activity. Bactericidal activity of polymers was further confirmed by time-kill studies. 
Due to their low hemolytic activity and highly selective bactericidal activity, these polymers may 

















4.5 1H NMR spectra of cationic amphiphilic polymers 
 
Figure 4.22 1H NMR spectrum of polymer PM6-90-PEG300 (600 MHz, D2O) 
 




Figure 4.24 1H NMR spectrum of polymer PM6-50-PEG300 (600 MHz, D2O) 
 




Figure 4.26 1H NMR spectrum of polymer PM6-20-PEG300 (600 MHz, D2O) 
 
 




Figure 4.28 1H NMR spectrum of polymer PM6-0-PEG300 (600 MHz, D2O) 
 




Figure 4.30 1H NMR spectrum of polymer PM6-70-PEG950 (600 MHz, D2O) 
 
 




Figure 4.32 1H NMR spectrum of polymer PM6-30-PEG950 (600 MHz, D2O) 
 




Figure 4.34 1H NMR spectrum of polymer PM6-10-PEG950 (600 MHz, D2O) 
 
 





Structural Parameters Affecting the Antibacterial and Hemolytic Activities of 
Cationic Amphiphilic Poly(vinyl esters) 
 
5.1 Introduction  
Incidents of infections involving multi drug-resistant bacteria are increasing worldwide at an 
alarming rate.125 Outbreaks of drug-resistant bacteria in hospitals are becoming dangerously 
common and lead to thousands of casualties and add billions of dollars in health-care costs in the 
United States alone.3, 126-127 Hospital-acquired infections are mostly associated with surface growth 
of bacteria on catheters and other medical devices.128 Coating of medical devices and other 
surfaces with antibacterial agents may prevent the proliferation of harmful bacteria.129 
Antibacterial polymers that kill bacteria by leaching bioactive agents such as heavy metals,130-134 
halogen species,135-137 and small biocide molecules,138-139 among others, have attracted significant 
research interest in the last couple of decades. These polymers suffer from limitations because they 
release toxic agents into environment, and leaching of bioactive agents renders them inactive after 
some time.126 In another approach to synthesize antibacterial materials, conventional antibiotics 
have been attached to polymer backbone to achieve antibacterial activity.140-143 These polymers 
may not be active against multi drug resistant bacteria, and widespread use of such materials may 
further enhance the rate of bacterial resistance development.   
As described in previous chapters, synthetic amphiphilic polyacrylates mimicking the structural 
features of natural antimicrobial peptides (AMPs) can show high antibacterial activity. Scanning 
electron microscopy analysis showed that amphiphilic polyacrylates disrupt the cell membranes 
of both gram negative E. coli and gram positive S. aureus bacteria. Thus, due to the membrane 
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rupture mechanism of antibacterial action, the development of bacterial resistance toward synthetic 
cationic amphiphilic polymers is highly hindered or improbable. Poly(vinyl acetate), a 
biocompatible material, has been widely used in paints, coatings, adhesives, and as binder for non-
woven materials.144-145 Cationic amphiphilic poly(vinyl esters) could be used in coatings with 
antibacterial properties, and thus may have large scale applications in homecare and healthcare 
settings, where nosocomial bacterial infections takes a huge toll on patient lives and healthcare 
costs.  
However, to the best of our knowledge, the antimicrobial activities of cationic amphiphilic 
poly(vinyl esters) have not been reported yet. Here we report the synthesis and antibacterial 
activities of cationic amphiphilic poly(vinyl esters) bearing quaternary ammonium groups. We 
synthesized a library of amphiphilic poly(vinyl ester) random copolymers with various molecular 
weights, lengths of alkyl side chain, and mole ratios of lipophilic repeating units. We found that 
majority of our copolymers manifested high antibacterial activity towards both E. coli and S. 
aureus.  
One of the disadvantages of poly(vinyl esters) such as poly(vinyl acetate) is their propensity to 
undergo base-catalyzed hydrolysis, which severely affects their weather resistant properties. 
Moreover, the relatively high glass transition temperature of poly 
(vinyl acetate) also limits its film-forming applications. Vinyl versatate (trade name VeoVa-10) is 
a commercially available vinyl ester monomer with highly branched and hydrophobic ten carbon 
atom side group. Vinyl versatate is a mixture of several structural isomers with different shapes of 
the decyl side group. Such a highly branched and hydrophobic side group would protect the esters 
linkages from alkali catalyzed hydrolysis.146-148 Furthermore, the highly hydrophobic side groups 
can provide the necessary hydrophobicity to the polymer chain, which is required for polymer 
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insertion in bacterial cell membrane. We synthesized a series of copolymers with varying mole 
ratios of vinyl versatate and counits with pendent cationic groups. The antibacterial and hemolytic 
activities of these polymers were assessed against bacteria and mouse Red blood cells (RBCs). A 
copolymer with just 10 mole% of vinyl versatate and 90 mole% of cationic counits displayed 46 
times more activity against gram S. aureus over RBCs.   
5.2 Experimental Section  
5.2.1 Materials  
Butyric acid (>99%), heptanoic acid (>99%), mercuric acetate (98%),   vinyl acetate (>99%), vinyl 
propionate (>98%),  sulfuric acid (99.99%), silica gel, tetrahydrofuran (anhydrous), 2,2’-azobis(2-
methylpropionitrile) (99%), methyl 3-mercaptopropionate (98%), acetonitrile (anhydrous), and 
N,N-dimethylethylamine (99%) were purchased from Sigma-Aldrich. Vinyl acetate and vinyl 
propionate were stirred with inhibitor remover for 20 minutes and filtered prior to use. All other 
chemicals were used without further purification. Valeric acid (99%) and hexanoic acid (>98%) 
were obtained from Alfa Aesar and were used as received. Dichloromethane, hexanes, and diethyl 
ether were purchased from BDH Chemicals. Vinyl versatate (VeoVa-10) was generously provided 
by Hexion Specialty Chemicals (now Momentive). 
5.2.2 Instrumentation 
1H and 13C NMR spectra for monomers and polymers were obtained on a Varian unity NMR 
spectrometer (600 MHz) using CDCl3 or DMSO-d6 as solvents. Molecular weights of precursor 
polymers were estimated using polystyrene standards on EcoSec HLC-83220 gel permeation 
chromatography instrument by Tosoh Bioscience, using tetrahydrofuran as eluent. To measure 
bacterial growth in E. coli and S. aureus cell culture, OD600 was obtained on Agilent 8453 
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spectrophotometer using 1 cm path length plastic cuvette. OD595 (antibacterial test) and OD414 
(hemolysis test) were obtained on a SpectraMax 340 PC micro plate reader from Molecular 
Devices. 
5.2.3 Synthesis of Monomers  
Vinyl butyrate, vinyl valerate, vinyl hexanoate, and vinyl heptanoate were synthesized by 
transvinylation reaction between vinyl acetate and corresponding acid, using mercuric acetate as 
catalyst (Scheme 5.1(a)).149-153 The representative synthesis procedure is described as follows. 
Heptanoic acid (20 mL, 141 mmol) was added into a 250 mL single round bottom flask, already 
charged with 0.4 mercuric acetate (1.26 mmol) and vinyl acetate (78 mL, 846 mmol). Sulfuric acid 
(0.07 mL, 1.32 mmol) was then added drop wise under stirring. The reaction mixture was stirred 
at 30 oC for 30 hours. Excess sulfuric acid was neutralized by adding 0.2 g sodium acetate, 
followed by filtration. Vinyl acetate was evaporated under reduced pressure, and the resultant 
liquid was purified using silica gel chromatography with dichloromethane eluent. Solvent was 
evaporated using a rotavapor and pure monomer was obtained as clear liquid (12.2 g. 55.4% yield). 
All other monomers were similarly synthesized.  1H NMR (600 MHz, CDCl3, δ) of vinyl 
heptanoate: 7.27 (q, J = 8 Hz, 1H), 4.86 (d, J = 13.9 Hz, 1H), 4.55 (d, J = 6.4 Hz, 1H), 2.37 (t, J 
= 7.5 Hz, 2H), 1.64 (m, 2H), 1.24-1.36 (m, 6H), 0.88 (t, J = 7 Hz, 3H); 13C NMR (600 MHz, 
CDCl3, δ) of vinyl heptanoate: 170.89, 141.23, 97.38, 33.92, 31.36, 28.68, 24.52, 22.42, 13.96; 
1H NMR (600 MHz, CDCl3, δ) of vinyl hexanoate: 7.27 (q, J = 6.2 Hz, 1H), 4.85 (d, J = 14.2 
Hz, 1H), 4.54 (d, J = 6.3 Hz, 1H), 2.36 (t, J = 7.7 Hz, 2H), 1.65 (m, 2H), 1.27-1.37 (m, 4H), 0.89 
(t, J = 7 Hz, 3H); 13C NMR (600 MHz, CDCl3, δ) of vinyl hexanoate: 170.89, 141.23, 97.38, 
33.89, 31.18, 24.28, 22.20, 13.84; 1H NMR (600 MHz, CDCl3, δ) of vinyl valerate: 7.28 (q, J = 




Scheme 5.1 a) Synthesis of monomers; b) synthesis of random copolymers followed by 
quaternization with N, N-dimethylethylamine. 
 
  
6.4 Hz, 1H), 2.39 (t, J = 7.6 Hz, 2H), 1.65 (m, 2H), 1.34-1.41 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H); 
13C NMR (600 MHz, CDCl3, δ) of vinyl valerate: 170.89, 141.23, 97.38, 33.68, 26.58, 22.20, 
13.63; 1H NMR (600 MHz, CDCl3, δ) of vinyl butyrate: 7.28 (q, J = 7.6 Hz, 1H), 4.87 (dd, J = 
13.9 Hz, 1H), 4.56 (dd, J = 6.4 Hz, 1H), 2.39 (t, J = 7.6 Hz, 2H), 1.65 (m, 2H), 1.34-1.41 (m, 2H), 
0.93 (t, J = 7.3 Hz, 3H); 13C NMR (600 MHz, CDCl3, δ) of vinyl butyrate: 170.58, 141.23, 97.38, 





5.2.4 Synthesis of random copolymers  
A representative synthesis procedure is described here (Scheme 5.1(b)). Vinyl heptanoate (1.56 g, 
10 mmol) and vinyl chloroacetate (1.20 g, 10 mmol) were added into a 100 mL 3 neck round 
bottom flask already charged with AIBN (0.0328 g), tetrahydrofuran (12 mL), and methyl 3-
mercaptopropionate (0.110 mL, 1 mmol) as chain transfer agent. The reaction flask was sealed and 
purged with nitrogen using a stainless steel needle for 5 minutes, followed by stirring under reflux 
at 65 oC for 20 hours. Excess solvent was evaporated under reduced pressure, and the resulting 
viscous polymer was dissolved in tetrahydrofuran and precipitated in hexane 3 times. The mole 
percentage of comonomers was calculated from 1H NMR and found to be in close agreement with 
feed mole percentage. Degree of polymerization was calculated using end group analysis from 1H 
NMR. Molecular weights were estimated using gel permeation chromatography. 1H NMR (600 
MHz, CDCl3, δ): 4.71-5.19 (bm, 37H), 3.97-4.14 (bs, 47H), 3.69 (s, 3H), 2.59-2.86 (m, 4 H), 2.17-
2.37 (bs, 35H), 1.48-2.09 (bm, 129H), 1.21-1.36 (bs, 107H), 0.83-0.92 (bs, 53H). Copolymers of 
vinyl versatate and vinyl chloroacetate were synthesized using similar procedures. CP-decyl5.5k-
30% (before quaternization) 1H NMR (600 MHz, CDCl3, δ): 4.64-5.19 (bm, 36H), 4.00-4.17 (bs, 









Figure 5.2 Gel permeation chromatography curves of copolymers prior to quaternization reaction. 
5.2.5 Quaternization of Copolymers 
 0.4 g of poly(vinyl heptanoate-Co-vinyl chloroacetate), as synthesized as described in section 
5.2.4, was dissolved in 30 mL anhydrous acetonitrile and added into a 100 mL single neck round 
bottom flask. The reaction mixture was sealed and degassed with nitrogen for 5 minutes. N, N-
dimethylethylamine (6 mL) was added while stirring, and the mixture was left under stirring at 
room temperature for 72 hours. Excess solvent was evaporated using a rotavapor under reduced 
pressure, and the polymer was re-dissolved in 2 mL methanol and precipitated in diethyl ether 
three times. The resulting polymer was kept under vacuum for 2 days and lyophilized to obtain 
quaternized polymer as a white powder (0.456 g). Complete quaternization was observed within 
the detection limit of NMR (Figure 5.3). 1H NMR (600 MHz, DMSO-d6, δ): 4.43-5.15 (bs, 68H), 
3.54-3.79 (bs, 39H), 3.15-3.38 (bs, 101H), 2.04-2.34 (bs, 41H), 1.35-2.01 (bm, 113H), 1.12-1.31 
(bs, 158H), 0.77-0.88 (bs, 53H). CP-decyl5.5k-30% (after quaternization) 
1H NMR (600 MHz, 




































5.2.6 Antibacterial and hemolytic activity of polymers 
Antibacterial activity of polymers in terms of Minimum Inhibitory Concentrations (MIC) and 
hemolytic activity of polymers in terms of HC50 were obtained as described in Chapter 2. 
5.3 Results and Discussion  
5.3.1 Synthesis and Characterization of Copolymers  
We synthesized a library of cationic amphiphilic poly(vinyl ester) random copolymers by free 
radical polymerization of vinyl ester monomers (Scheme 5.1 and Table 5.1). Vinyl chloroacetate 
was copolymerized in an equimolar ratio (1:1) with a range of hydrophobic vinyl ester monomers 
with varying side group lengths from methyl to decyl. The length of side group was varied from 
methyl to decyl in order to explore the effect of amphiphilic balance of copolymers on their 
biological activities. The balance of hydrophobic to cationic moieties in polymers is essential for 
bacterial cell membrane permeability of polymers. Vinyl chloroacetate counits in the precursor 
copolymers were quaternized with N, N-dimethylethylamine to generate cationic groups in the 
copolymers. Precursor copolymers were treated with excess N, N-dimethylethylamine at room 
temperature for 72 hours to ensure complete quaternization. Complete quaternization was 
observed within the detection limit of NMR. The molecular weights of the precursor polymers 
(before quaternization) were assessed using GPC (Table 5.1 and Figure 5.2). Notation of CP-
alkylxk represents different copolymers. For example, CP-butyl7k denotes the copolymer having n-
butyl group in the side chain and molecular weight (Mw, GPC) around 7k g/mol. 1H NMR was 
used to calculate the degree of polymerization, mole ratio of hydrophobic to cationic repeating 
units, and to characterize precursor and quaternized copolymers. 
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The monomer vinyl versatate has a highly hydrophobic side chain of ten C-atoms. Vinyl versatate 
monomer is a mixture of several structural isomers with various shapes of decyl side chain. Such 
a highly hydrophobic side group is expected to protect ester functional groups from hydrolysis, 
thus improving the stability of polymers. Moreover, hydrophobic decyl side groups provides 
hydrophobicity to the copolymers, which is essential for membrane rupturing ability of these 
copolymers. Vinyl versatate was copolymerized with vinyl chloroacetate at various mole ratios in 
order to explore the effect of relative compositions of hydrophobic and cationic groups in 
copolymers on their biological activities. The feed mole% of hydrophobic vinyl versatate was 
varied from 0% to 60%, in increments of 10 mole%. Cationic charge was generated in the 
copolymers through quaternization reaction with N,N-dimethylethylene amine. Quaternized 
copolymers with more than 60 mole% were found to be insoluble in water, and their biological 
activities were not evaluated. Each copolymer was synthesized at three molecular weight levels by 
adjusting the feed mole ratio of monomers to methyl 3-mercaptopropionate, used as a chain 
transfer agent (Table 5.1). 1H and 13C NMR were used to characterize the precursor and 
quaternized copolymers. The notation CP-decylxk-Y% is used to represent the copolymer with Y 








Table 5.1 Characterization and biological data of quaternized random copolymers containing 
different lengths of alkyl side chain at various molecular weights. 
Copolymer 




































































































































































































5.3.2 Biological activity of poly(vinyl esters) with various lengths of alkyl side chains 
5.3.2.1 Antibacterial Activity  
Antibacterial activities of quaternized copolymers were assessed against gram negative E. coli and 
gram positive S. aureus in terms of minimum inhibitory concentrations (MIC). MIC values of 2.3k 
g/mol series copolymers are as shown in Figure 5.4 and Table 5.1. CP-methyl2.3k and CP-ethyl2.3k 
were found to be inactive against E. coli. However, increasing the length of the side chain to three 
carbon atoms (CP-propyl2.3k) led to substantial increase in antibacterial activity against E. coli. 
This observation is in accordance with the membrane rupture mechanism of cationic amphiphilic 
polymers, as polymer hydrophobicity promotes bacterial cell membrane rupture through lipophilic 
interactions with the hydrophobic core of lipid bilayer. Further increase in the length of 
hydrophobic side chain led to a gradual increment in antibacterial activity with CP-hexyl2.3k 
displaying the highest antibacterial activity in 2.3k g/mol series. CP-decyl with highly hydrophobic 
side groups displayed lower antibacterial activity (MIC 62 µg/ml) than CP-hexyl.  
In 4k g/mol and 7k g/mol series copolymers, CP-methyl and CP-ethyl were found to be inactive 
against E. coli (Figures 5.5 and 5.6), similar to their lower molecular weight counterparts (CP-
methyl2.3k and CP-ethyl2.3k). Increase in side group length to propyl led to substantial increase in 
antibacterial activity against E. coli, reached a maxima at butyl, but further increase in side group 
length resulted in lower antibacterial activity.  Similar observations of attaining a maxima of 
antibacterial activity at a certain length of alkyl side chain, and lower antibacterial activity at lower 
or higher length of alkyl side chain have been reported in “facially amphiphilic” polynorbornens.21 
An optimum level of overall hydrophobicity is required in polymers for lipophilic interactions with 
bacterial cell membrane. However, increasing the length of the alkyl side chain may decrease the 
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water solubility. At higher lengths of alkyl side chains, the lower water solubility of polymers may 
lead to associations of polymer chains leading to reduction in the concentration of polymer chains 
available to bind to the bacterial cell surface.  Moreover, a balance of cationic and hydrophobic 
components in polymers is required to effectively interact with the negatively charged murein 
layer and lipophilic lipid bilayer (phospholipids) core of bacterial cell surface. In 4k g/mol and 7k 
g/mol series copolymers, CP-butyl demonstrated the highest antibacterial activity for E. coli, but 
CP-hexyl2.3k showed the highest activity against E. coli in 2.3k g/mol series copolymers. Smaller 


























Figure 5.5 Antibacterial activity of 4k g/mol series copolymers against E. coli and S. aureus. 
 









































Figure 5.7 Hemolytic activities of copolymers against RBCs. 
for bacterial membrane rupture ability. Moreover, CP-hexyl2.3k displayed highest antibacterial 
activity toward E. coli among all polymers in this study. A copolymer with lower molecular 
weight has a higher molar concentration of active polymer molecule in a given weight as 
compared with higher molecular weight copolymers, leading to higher antibacterial activity. 
The MIC values of our quaternized copolymers against S. aureus are as shown in Figures 5.4 to 
5.6 and Table 5.1. Similar to activity against E. coli, a combination of low molecular weight (2.3k 
g/mol) and long alkyl side chain led to highest antibacterial activity against S. aureus. CP-
pentyl2.3k, CP-hexyl2.3k, and CP-decyl2.3k manifested the lowest MIC value against S. aureus, among 
all of our copolymers. CP-methyl2.3k and CP-ethyl2.3k were inactive against S. aureus, in 
congruence with their activity against E. coli. However, with increase in molecular weight (4k and 
7k g/mol), CP-ethyl displayed some antibacterial activity against S. aureus. Similar to activity 
against E. coli, an increase in alkyl side chain length from ethyl to propyl led to substantial increase 






















atoms in the side chain is the threshold, below which no significant antibacterial activity was 
observed in these copolymers.  
Copolymers with alkyl side chains from propyl to hexyl are more antibacterial towards S. aureus 
as compared to E. coli. As described in previous chapters, gram negative E. coli and gram positive 
S. aureus have significantly different cell wall structures. Double membrane structure of E. coli 
may be more difficult to penetrate as compared to the single membrane structure of S. aureus. 
Moreover, the negatively charged peptidoglycan or murein layer is only 6-8 nm thick in E. coli, 
and is also sandwiched between the outer and inner membrane.20 In comparison to E. coli, the 
surface of S. aureus is covered by a 20-80 nm thick negatively charged murein layer. Therefore, 
cationic copolymers may have more electrostatic interactions with S. aureus as compared to E. 
coli. Hence, one or both these factors may have contributed to higher antibacterial activity of our 
copolymers against S. aureus.  
5.3.2.2 Hemolytic Activity 
In order to ascertain the cytotoxicity of our quaternized copolymers toward mammalian cells, we 
evaluated the hemolytic activity of quaternized copolymers against freshly drawn mouse RBCs. 
HC50 values for quaternized copolymers are shown in Figure 5.7 and Table 5.1. All copolymers, 
except CP-methyl and CP-ethyl, displayed high toxicity towards RBCs. The lack of significant 
hemolytic and antibacterial activity in CP-methyl and CP-ethyl copolymers suggests that they do 
not have ability to rupture cell membranes of either erythrocytes or prokaryotes. The outer surface 
of RBCs’ cytoplasmic membrane consists of zwitterionic phospholipid head groups and thus lack 
net charge on its outer surface. Therefore, hemolytic activity of cationic amphiphilic polymers 
primarily arise from the hydrophobic interactions between lipophilic part of lipid bilayer, and the 
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hydrophobic moieties in amphiphilic copolymers. CP-propyl2.3k and CP-butyl2.3k displayed lower 
hemolytic activity as compared to their higher molecular weight counterparts, but CP-pentyl, CP-
hexyl, and CP-decyl were highly hemolytic (HC50 <7 µg/mL) at all three molecular weight levels.  
5.3.3 Effect of cationic and hydrophobic counits composition on the biological activity of 
poly(vinyl esters) 
5.3.3.1 Antibacterial Activity  
Vinyl versatate was copolymerized with vinyl chloroacetate at various mole ratios in order to 
explore the effect of relative compositions of hydrophobic and cationic groups in copolymers on 
their biological activities. The notation CP-decylxk-Y% is used to represent the copolymer with Y 
mole% (in feed) of vinyl versatate counits and has an estimated molecular weight of xk g/mol. As 
is apparent from Figures 5.8 to 5.10, homopolymers of vinyl chloroacetate are not active against 
E. coli (MIC > 1000 µg/mL). Incorporation of just 10 mole% of vinyl versatate counits led to 
significant reduction in MIC value. CP-decyl11k-10% displayed substantial antibacterial activity 
against E. coli. Further increments in vinyl versatate mole% resulted in higher antibacterial activity 
and copolymers with ~ 30-40 mole% of vinyl versatate displayed highest antibacterial activity in 
the 2.3k and 5.5k g/mol series copolymers. In 2.3k g/mol series polymers, further increase in vinyl 
versatate mole% did not result in higher antibacterial activity, whereas in 5.5k g/mol series 
copolymers we observed a reduction in antibacterial activity of copolymers with greater than 40 
mole% of vinyl versatate counits. Similarly, antibacterial activity decreased with higher than 30 
mole% of vinyl versatate in 11k g/mol series polymers.  
Hence, 20-30 mole% of vinyl versatate is the optimum mole% of vinyl versatate at which the 
highest activity against E. coli was observed. Quaternized homopolymers of vinyl chloroacetate 
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have low overall hydrophobicity and high cationic charge density, which would impede the ability 
of polymers to penetrate through the hydrophobic core of lipid bilayer. Incorporation of up to 30 
mole% of lipophilic vinyl versatate groups led to higher antibacterial activity due to higher 
lipophilic interactions of polymers with cell membrane. However, further incorporation of 
hydrophobic comonomer led to a reduction in antibacterial activity. Number of cationic groups in 
the polymer reduces with increasing mole% of vinyl versatate, resulting in lower electrostatic 
interactions of polymers with bacterial cell surface. Furthermore, highly hydrophobic decyl side 
groups of vinyl versatate would reduce the solubility of polymers in the aqueous assay medium, 
particularly at higher mole%’s of vinyl versatate. The reduction in polymer solubility may 
facilitate the hydrophobic association of polymer chains resulting in lower effective concentration 
of polymer available to attack bacterial cells. Hence, a balance between hydrophobic and cationic 













Table 5.2 Characterization and biological data of quaternized random copolymers containing 











































































































































































Figure 5.8 Antibacterial and hemolytic activities of 2.3k g/mol series quaternized Poly(vinyl 
versatate-co-vinyl chloroacetate) polymers. 
 
Figure 5.9 Antibacterial and hemolytic activities of 5.5k g/mol series quaternized Poly(vinyl 














































































































































































Figure 5.10 Antibacterial and hemolytic activities of 11k g/mol series quaternized Poly(vinyl 
versatate-co-vinyl chloroacetate) polymers. 
MIC values of polymers were obtained against gram positive S. aureus (Figure 5.8-5.10 and Table 
5.2). Except CP-decyl2.3k-0%, all polymers displayed high antimicrobial activity toward S. aureus. 
In 2.3k g/mol series, addition of 10 mole% of vinyl versatate led to a substantial increase in activity 
against S. aureus. Antibacterial activity toward S. aureus increases with further increase in vinyl 
versatate mole% with CP-decyl2.3k-30% to CP-decyl2.3k-60% showing very high antibacterial 
activity (MIC = 12 µg/mL). This observation is in contrast with antibacterial activity of 11k g/mol 
series copolymers, in which a significant reduction in antibacterial activity was observed in 
polymers with higher than 30 mol% of vinyl versatate. Hence, lower molecular weight polymers 
require higher mole% composition of hydrophobic counits in copolymers to achieve high 
antibacterial activity. It is interesting to note that the antibacterial activity of polymers with 0% 
and 10% vinyl versatate increased with higher molecular weight, whereas the antibacterial activity 
























































































antibacterial activity of the CP-decyl11k series polymers is significantly lower than the antibacterial 
activity of the CP-decyl2.3k series polymers in the range of 20-60 mole% vinyl versatate. In 
polyacrylate homopolymers (chapter 2), we observed the similar effect of molecular weight as 
higher molecular weight homopolymers were antibacterial, but lower molecular weight 
homopolymers were inactive against bacteria.  
5.3.3.2 Hemolytic activity 
CP-decyl2.3k-0% and CP-decyl2.3k-10% showed very low hemolytic activity toward mouse RBCs. 
2.3k g/mol series copolymers with higher than 10 mole% of vinyl versatate counits displayed very 
high hemolytic activity (Table 5.2 and Figures 5.8 - 5.10). Similarly, CP-decyl5.5k-0% and CP-
decyl5.5k-10% demonstrated very low hemolytic activity, but copolymers in 5.5k g/mol series with 
higher than 10 mole% vinyl versatate were found to have extremely high lytic ability toward RBCs 
(HC50 <7 µg/mL). In 11k g/mol series copolymers, except homopolymer CP-decyl11k-0%, all 
copolymers displayed 100% hemolysis at the lowest polymer concentration tested (HC50 <7 
µg/mL). Low hemolytic activity of homopolymers and copolymers with up to 10 mole% vinyl 
versatate could be attributed to lower hydrophobicity of polymers. As discussed earlier, the lipid 
bilayer of RBCs consist of zwitterionic phospholipids, thus lacking net negative charge on the 
outer surface of cytoplasmic membrane. High hemolytic activity of amphiphilic polymers arises 
from the hydrophobic interactions of polymer chains with RBC lipid bilayer. Quaternized 
homopolymers displayed selective (selectivity = HC50/MIC) antibacterial activity toward S. aureus 
over RBCs. CP-decyl11k-0% was found to be 21 times more active against S. aureus over RBCs. 




5.4 Conclusions  
In this study, we synthesized a library of cationic amphiphilic poly(vinyl ester) copolymers, and 
evaluated their antibacterial and hemolytic activities. The majority of the quaternized copolymers 
displayed high antibacterial activity towards E. coli and S. aureus. The role of alkyl side group 
length was investigated on the antibacterial and hemolytic activities of poly(vinyl esters). We 
found that the combination of lower molecular weight and six carbon atoms in the side group 
resulted in highest antibacterial activity towards both E. coli and S. aureus. In case of higher 
molecular weight copolymers (4k and 7k series), maximum antibacterial towards E. coli was 
achieved with 4 carbon atoms in the side chain, and further increase in the length of side group 
from four to six carbon atoms led to reduction in activity against E. coli.  On the other hand, 
quaternized copolymers with very short alkyl side groups (methyl and ethyl) were inactive against 
both E. coli and S. aureus. Therefore, the molecular weight and length of alkyl side group is critical 
to achieve superior antibacterial activity of these quaternized poly(vinyl esters). We found that 
most of the copolymers were more active towards S. aureus as compared to E. coli. Such difference 
in activity may have resulted from significant difference in the cell surface morphology of E. coli 
and S. aureus. All copolymers, except CP-methyl and CP-ethyl, were highly hemolytic against 
mouse RBCs. Copolymers with varying degrees of amphiphilicity were synthesized through 
copolymerizing lipophilic vinyl versatate monomer with vinyl chloroacetate, at various mole 
ratios. Most of the polymers displayed high activity against S. aureus. CP-decyl5.5k-10% with 90 
mole% cationic counits and 10 mole% hydrophobic counits displayed 46 times more activity 
against S. aureus over RBCs. Thus, incorporation of around 10 mole% of highly hydrophobic 
monomer led to highly selective antibacterial activity. These amphiphilic polymers with excellent 
antibacterial activity against both gram negative E. coli and gram positive S. aureus, makes them 
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promising candidates to curb the burgeoning problem of multidrug resistant bacteria on surfaces 
in hospitals, in sanitation, and numerous other surfaces that do not come in direct contact with 
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